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ABSTRACT
CANONICAL NUCLEAR FACTOR-KAPPA B SIGNALING IN SATELLITE STEM
CELL HOMEOSTASIS AND FUNCTION
Alex R. Straughn
July 16, 2018
Satellite cells are adult stem cells that are required for the regeneration of skeletal
muscle following injury. However, the signaling mechanisms that regulate satellite stem
cell homeostasis and function in adult animals remain less understood. Nuclear factorkappa B (NF-κB) is a major nuclear transcription factor that regulates the gene
expression of a plethora of molecules involved in cellular proliferation, differentiation,
survival, and the inflammatory immune response. NF-κB can be activated through a
canonical or non-canonical pathway. However, the role of canonical NF-κB signaling in
the regulation of satellite stem cell function during skeletal muscle regeneration has not
been yet investigated using genetic mouse models. In the present work, we demonstrate
that physiological levels of activation of the canonical NF-κB pathway promotes satellite
cell proliferation, survival, and differentiation. Satellite cell-specific inducible deletion of
Inhibitor of Kappa B Kinase β (IKKβ), a critical kinase of the canonical NF-κB pathway,
attenuates muscle regeneration in adult mice. Targeted ablation of IKKβ also reduces the
number of satellite cells and their fusion to injured skeletal muscle of adult mice.
Inhibition of canonical NF-κB pathway causes precocious differentiation of satellite cells
both ex vivo and in vitro. We also found that siRNA-mediated knockdown of components
v

of the canonical NF-κB pathway reduces the survival of cultured satellite cells.
Intriguingly, our results also demonstrate that supra-physiological activation of canonical
NF-κB inhibits satellite stem cell function during skeletal muscle regeneration.
Overexpression of a constitutively active mutant of IKKβ (IKKβca) in satellite cells
attenuates initial stages of myofiber regeneration following injury. While not affecting
their self-renewal, overexpression of IKKβ causes precocious differentiation of satellite
cells. Furthermore, our results suggest that constitutive activation of canonical NF-κB
pathway inhibits proliferation and reduces survival of satellite cells. Lastly, we found that
inducible expression of IKKβca in satellite cells was insufficient to rescue the
regenerative deficits observed in satellite cell-specific TAK1-knockout mice. Altogether,
our study suggests that a tight regulation of canonical NF-κB pathway is important for
maintaining satellite cell pool and skeletal muscle regeneration.
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CHAPTER 1

GENERAL INTRODUCTION

1.1 Embryological Development of Skeletal Muscle. Skeletal muscle is the most
abundant tissue type in the human body that consists of multinucleated myofibers.
Formation of skeletal muscle is a multistage process involving the hierarchical expression
of various transcription factors and regulatory proteins. During the embryological
development of skeletal muscle, mesodermal cells exit the primitive streak and proceed
to migrate antero-laterally [1]. As the cells migrate out of the primitive streak, they
spatially segregate to form both the axial and the paraxial mesodermal structures [1].
Various signaling molecules, such as: bone morphogenetic proteins (BMPs), the
Wingless-related integration site (Wnt) pathway, and Noggin, a downstream target of
Wnt signaling, are responsible for the organization and expansion of the paraxial
mesoderm following the cellular migration from the primitive streak [2]. The paraxial
mesodermal cells are responsible for the generation of somites, which are blocks of tissue
that flank the neural tube [3]. The somites subsequently differentiate and give rise to the
dermomyotome, and other embryologically-derived cell types. After the cells in the
dermomyotome proliferate, they differentiate and give rise to the dermatome, which is
the embryological tissue responsible for the generation of the dermis, and the myotome,
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which subsequently leads to the generation of muscle [2-4]. The myotome divides
spatially into a hypaxial portion and an epaxial portion [4, 5]. The hypaxial portion of the
myotome gives rise to muscles of the anterior abdominal wall, as well as the skeletal
musculature of the thoracic wall [4, 6]. Proliferation and subsequent migration of cells in
the epaxial portion of the myotome leads to the formation of the musculature of the trunk,
as well as the extensor muscles of the neck [4, 6].
During and following the embryological orchestration of skeletal muscle
patterning, the embryologically-derived skeletal muscle tissue signals for the production
of more skeletal muscle, such that the musculoskeletal system can be fully developed.
Myogenesis (the process of skeletal muscle formation) is required not only for
development of skeletal muscle during embryogenesis, but it is also essential for the
maintenance, growth, and repair of myofibers following injury [7]. The process of
myogenesis can be divided into several stages to aide in understanding the molecular
mechanisms orchestrating the formation of skeletal muscle. Myogenesis starts with the
process of delamination and ends with the formation of specific skeletal muscles.
Delamination is initiated by the genetic factor Paired-box 3 (Pax3), which mediates the
transcription of protein tyrosine kinase Met (c-Met) [8]. Pax3 is expressed in hypaxial
cells that are migrating, but is not expressed in cells that lead to development of the facial
muscles [9]. c-Met-mediated signaling initiates the generation of lamellipodia in the
nascent myoblasts, thereby conferring them the capability to migrate to its future resident
area [10].
The next component of myogenesis is migration, which orchestrates the
organization of the developing dorsal forelimb [11]. Ladybird Homeobox 1 (LBX1) is
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critical for the development of the dorsal forelimb post-delamination, as signaling
through LBX1 stimulates the proliferation of myoblasts [4, 8, 12]. The proliferation of
myoblasts in the developing dorsal forelimb in turn populates this region with skeletal
muscle progenitors, such that further limb development can occur [12]. The signaling
molecule c-Met continues to be upregulated during this stage of myogenesis and
continues to orchestrate the migration of the newly generated myoblasts [4, 8, 10].
After the newly derived myoblasts have migrated to their target region, the
embryologically derived myoblasts will rapidly undergo proliferation and eventually will
be signaled to differentiate, thereby completing the next two components of myogenic
signaling. The myoblasts are signaled to induce gene expression of various myogenic
regulatory factors (MRFs) [13]. The first MRF to be expressed is Myogenic factor 5
(Myf-5) on embryological development day 8 to facilitate the proliferation of myoblasts
[13]. Myogenin and Myoblast determination protein 1 (MyoD/MyoD1) are the next
MRFs to be expressed to initiate the differentiation of the expanded population of
myoblasts [14, 15]. MyoD also inhibits self-renewal of myogenic cells [16].
With the expression of MyoD, the myoblasts have entered the myogenic stage of
determination. In this facet of myogenesis, Pax7 is down-regulated and MyoD is
concurrently up-regulated [17]. The myoblasts subsequently differentiate into myocytes
as a result of the expression of MyoD and other signaling molecules [13, 18-20].
Following this differential signaling paradigm, the myocytes are signaled to fuse with
each other to form primary myotubes, which will subsequently fuse with more myocytes
in a process termed secondary fusion that ultimately culminates in the generation of
mature myofibers (Figure 1.1) [13, 18-20].
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The expression pattern of Myf-5 is only transient, whereas MRF4, Myogenin, and
MyoD are expressed in perpetuity [15]. As the developing embryo gestates and
undergoes the myogenic process, the signaling molecules LBX1 and Mesenchyme
Homeobox 2 (Mox2) facilitate specific muscle formation in conjunction with numerous
other proteins, thereby finalizing the process of myogenesis [4, 8, 21]. To allow mature
development of the musculoskeletal system, LBX1 continues to stimulate the
proliferation of myoblasts [12] and Mox2 signaling is regulated in a spatiotemporal
fashion to allow specific appendicular muscle formation [22].

1.2 Skeletal Muscle Injury and Regeneration Pattern. Despite skeletal muscle being a
terminally differentiated cell type, it has the amazing capability to repair itself following
injury due to a self-sustaining population of undifferentiated precursor cells, termed
satellite cells [23]. After an acute injury to skeletal muscle, a multitude of signaling
cascades are activated from the damaged muscle and surrounding cells to assist in the
recovery/regeneration of the injured skeletal muscle [23]. The injury and subsequent
regeneration process, termed regenerative myogenesis, follows a stereotypical pattern
that is mediated primarily by satellite cells [24]. By day one post-injury, a necrotic
muscle environment is generated and there is a robust invasion of the injured tissue by
numerous inflammatory cells [24]. By day three post-injury, an abundance of
mononuclear cells are recruited to the injured skeletal muscle [24]. Following this, the
production of myoblasts is signaled to facilitate a repair of the damaged
microenvironment [24]. In tandem, the myoblasts will proliferate, differentiate, and
subsequently fuse with each other and pre-existing myofibers while the infiltrating
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immunocytes are cleared [24]. Three weeks post-injury, the invading inflammatory cells
have been mostly cleared due to phagocytic macrophage activity to the point that the
injured skeletal muscle tissue has returned to a normal physiological appearance, with the
exception of the injured myofibers being centrally multinucleated as a byproduct of
myoblast fusion [24].
As briefly alluded to, several immunocytes play a role in the regenerative process
post-injury [25]. Following an acute skeletal muscle injury, the sarcolemma of skeletal
muscle is disrupted, which leads to an extravasation of various myokines (chemokines
released from skeletal muscle) that aide in the recruitment of immune cells to the injured
microenvironment [26-28]. Several adaptor signaling proteins, such as Myeloid
Differentiation Primary Response 88 (MyD88), TIR-domain-containing Adaptorinducing Interferon-β (TRIF), Translocation Associated Membrane Protein (TRAM), and
TIR-domain-containing Adaptor Protein (TIRAP), mediate Toll-like Receptor (TLR)
signaling cascades that result in the activation of NF-κB, Interferon Regulatory Factors,
and other signaling pathways [26, 29]. TLRs allow for the recognition of DamageAssociated Molecular Patterns (DAMPs) and Pathogen-Associated Molecular Patterns
(PAMPs), making them ideally suited for signaling during regenerative myogenesis [26].
TLR-mediated signaling pathways also allow for the production of various myokines and
induce the generation of pro-inflammatory cytokines [26-29].
Post-injury, various immunocytes are recruited from peripheral tissues to the
damaged skeletal muscle microenvironment. Neutrophils are the first cell type to be
recruited and typically infiltrate the skeletal muscle within an hour following injury and
increase in number peaking around 24-hours post-injury [27]. After the skeletal muscle is
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infiltrated by neutrophils, phagocytic macrophages, initially responsible for phagocytosis
of cellular debris, invade the injured skeletal muscle and peak in number 48-hours postinjury [27]. The macrophages are signaled to express various monocyte chemoattractant
proteins [30]. Peripherally, monocytes are being generated in the bone marrow due to
signaling from the damaged skeletal muscle [27]. These monocytes are recruited to the
site of injury due to the macrophage-mediated expression of monocyte chemoattractant
proteins, where they will subsequently differentiate into phagocytic M1 macrophages or
into non-phagocytic M2 macrophages [27, 30]. The M1 macrophages have a proinflammatory role and are responsible for mediating the subsequent recruitment of more
M1 macrophages, as well as M2 macrophages [31]. The M1 macrophages provide an
initial cellular benefit from the recruitment of non-resident immunocytes, but prolonged
expression and activity of the phagocytic macrophages can worsen the degree of
inflammation and injury in the damaged skeletal muscle microenvironment [31, 32]. The
M2 macrophages arise during a relatively later stage during the process of regeneration
and mediate a transition from a protectant pro-inflammatory phase into an antiinflammatory phase that allows for the facilitation of repair [32].

1.3 Satellite Cells. Skeletal muscle contains a group of undifferentiated precursors that
are maintained in a quiescent state, termed satellite cells. Under uninjured conditions, the
satellite cells reside between the basal lamina and the sarcolemma [23]. Quiescent, or
inactive, satellite cells can easily be identified by their expression pattern of certain
myogenic markers, such as: Pax7, CD34, and M-Cadherin [33]. After sustaining an
injury, the previously inactive satellite cells are rapidly activated to facilitate repair of
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damaged skeletal muscle (Figure 1.2) [34]. A population of these satellite cells
tentatively commits to the myoblast lineage and expresses various myogenic markers,
such as: α7-integrin, Myf-5, MyoD, and Pax7 [33]. Pax7, in conjunction with other
signaling molecules, such as MyoD, determine the fate of the satellite cells [17, 35].
Activated satellite cells destined to facilitate with the repair process will usually undergo
an up-regulation of MyoD [17]. These satellite cells will simultaneously up-regulate
-

+

MyoD and down-regulate Pax7 to the point that they become Pax7 /MyoD and have
committed to the myogenic lineage to facilitate repair of injured myofibers [17].
Alternatively, satellite cells can self-renew their population through a down-regulation of
MyoD and undergo asymmetric cell division [17]. This replenishment of the satellite cell
pool through asymmetric division, common in numerous stem cell types, provides a
means for skeletal muscle to repair future injuries by maintaining a resident population of
the undifferentiated precursor cell type [33].

1.4 Signaling Mechanisms in Regeneration. It is now evidenced that a number of
signaling pathways are activated in skeletal muscle of adults following injury. The
majority of the signaling mechanisms are activated in injured myofibers and satellite stem
cells [23]. However, several other cell types do play a role in the repair of skeletal
muscle. For example, immunocytes that infiltrate the muscle following necrotic injury
initiate signaling pathways that orchestrating changes in the cellular immune response
[23]. There is also evidence for non-muscle adult stem cells, such as certain
hematopoietic stem cells, being recruited to assist in skeletal muscle regeneration [36].
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Below, I discuss a group of signaling mechanisms that mediate various facets of skeletal
muscle regeneration [23].
Several fibroblast growth factors (FGFs) have been implicated in regenerative
myogenesis, although some with seemingly contradictory results [23, 37-40]. FGF-6 has
a muscle specific expression pattern and signaling increases post-injury [37]. Prior
reports indicate that the skeletal muscle of mice lacking FGF-6 is still capable of
undergoing regeneration despite its reported role in cellular signaling following an acute
muscle injury [38]. FGF-2 is a stimulus for myoblast activation [39] and has also been
shown to increase the proliferation of satellite cells, thereby improving muscle
regeneration [40].
On similar lines, Insulin-like Growth Factors (IGFs) also play important role in
the regulation of myogenesis [41-43]. IGF-I and IGF-II lead to changes in the gene
expression patterns of various MRFs that regulate numerous facets of the myogenic
process [43]. IGF-I results in skeletal muscle hypertrophy through the activation of
satellite cells and their subsequent proliferation, as well as through stimulating an
increase in the rate of protein synthesis in pre-existing skeletal muscle [44-47]. IGF-II
activity, mediated by mechanistic target of Rapamycin (mTOR) signaling, results in
changes to IGF-II promoter 3 transcriptional activity, conferring an enhanced
differentiation of the previously generated myoblasts signaled through IGF-I [48].
Conversely, the Transforming Growth Factor-β (TGF-β) family of cytokines
inhibits regenerative myogenesis [49]. Members of the TGF-β family have been shown to
inhibit proliferation and differentiation of myoblasts within the context of regenerative
myogenesis [50, 51]. The impairment to skeletal muscle regeneration mediated by TGF-
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β1 occurs through down-regulation of basic fibroblast growth factor (bFGF) and IGF1
signaling, which causes a decrease in myoblast proliferation [50]. Another member of the
TGF-β family, Myostatin (also known as Growth and Differentiation Factor-8), has been
implicated in the inhibition of regenerative myogenesis [52]. Prior reports have shown
that the skeletal muscle of Myostatin-deficient mice displays both hyperplasia and
hypertrophic growth of myofibers within skeletal muscle [52]. Further, the levels of
Myostatin have been found to be up-regulated following necrotic muscle injury [53]. It
has been suggested that Myostatin acts as a chemoattractant thereby mediating TGF-β
signaling and the recruitment of macrophages in the injured muscle environment [53].
Hepatocyte Growth Factor (HGF), also known as Scatter Factor, is a critical
growth factor with respect to tissue regeneration [54]. HGF transcript levels are increased
during the early stages of injury in a manner proportional to the severity of skeletal
muscle injury [55-57]. Other studies have shown that HGF activates quiescent satellite
cells and increases their proliferation, while simultaneously inhibiting their
differentiation, thereby facilitating the early stages of regenerative myogenesis [56].
Downstream signaling through HGF and the canonical NF-κB pathway act
antagonistically upon each other to either facilitate the differentiation or the proliferation
of myoblasts, respectively [58]. Later stages of regenerative myogenesis show a
decreased expression of HGF, possibly to allow the proliferating satellite cells to
differentiate and fuse with injured myofibers [56].
Leukemia Inhibitory Factor (LIF) is a member of the Interleukin-6 cytokine
family and has been shown to play a very specific role in regenerative myogenesis [59].
LIF appears to augment myoblast proliferation via the activation of Janus Kinase 2
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(JAK2)-Signal Transducer and Activators of Transcription Protein 3 (STAT3) signaling,
but does not affect the differentiation or subsequent fusion of myoblasts [60, 61]. Despite
its structural homology to LIF, IL-6 does not appear to affect regenerative myogenesis
[62, 63]. Despite no definitive role in regenerative myogenesis, IL-6 regulates protein
synthesis, skeletal muscle adaptation to contraction, and cancer-induced muscle atrophy
[64].

1.5 Satellite Cell Signaling. Satellite cells are inextricably linked to regenerative
myogenesis. Indeed, satellite cells are connected to a multitude of different signaling
pathways that exhibit crosstalk between each other, thereby resulting in a complex
signaling network within the satellite cells [65]. Some of these pathways signal for the
self-renewal of satellite cells [33, 35, 66, 67], whereas others promote escape from
quiescence and progression into myogenic lineage [68-71]. Asymmetric division of the
satellite cells is a hallmark of self-renewal [33], whereas the symmetric expansion of
satellite cells is indicative of a commitment to the myogenic lineage [17, 35]. Discussed
below are various signaling pathways that modulate whether the satellite cells will
undergo self-renewal or whether they will activate and subsequently differentiate to
facilitate the repair of injured skeletal muscle.
One of the pathways involved with the self-renewal of satellite cells is the Notch
signaling cascade. This pathway is initiated when a Notch ligand, such as Delta-like
(DLL) 1 or 4 or Jagged 1 or 2, binds to an adjacent cell that has a Notch Receptor, Notch
1-4 [66]. The Notch receptor undergoes proteolytic cleavage, thereby freeing the Notch
Intracellular Domain (NICD) to translocate to the nucleus [72]. NICD binds to
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Recombining Signal Binding Protein for Immunoglobulin Jκ (RBP-Jκ), a transcriptional
repressor. Binding of NICD results in a conformational change in RBP-Jκ, resulting in
the formation of a transcriptional activator [72]. Basal levels of Notch activity have been
shown to be critical in the maintenance of quiescent satellite cells [73]. Published reports
demonstrate that a subset of quiescent satellite cells express a high level of Notch activity
[35]. Other studies showed that the forced expression of Notch signaling was sufficient to
restore the regenerative capability of aged myofibers, lending further support to its
critical role in the maintenance of pool of satellite cells [74].
The signaling pathways of four mitogen-activated protein kinases (MAPKs)—
extracellular signal–regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK), p38,
and ERK5 are among the most well-characterized cell-signaling pathways that are
activated in response to various extracellular stimuli and regulate pluripotent cellular
function in almost all cell types. Signaling through Angiopoietin 1, and its receptor Tie-2,
is mediated through the ERK1/2 pathway and has been shown to play an anti-myogenic
role that results in the quiescence of satellite cells [67]. The ERK1/2 signaling pathway is
activated by various cytokines that act to orchestrate proliferation by regulating
progression through the cell cycle and apoptosis [75-79]. Tie-2 was shown to be
expressed in quiescent satellite cells and the expression decreased with the activation and
subsequent differentiation of satellite cells [67]. When the ERK1/2 pathway is silenced in
satellite cells, they begin to up-regulate numerous pro-myogenic markers that cause the
satellite cells to undergo proliferative expansion, followed thereafter by their
differentiation [67].
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The JNK signaling pathway is inextricably linked to satellite cells and the process
of myogenesis [80]. JNK is activated by various growth factors, pro-inflammatory
cytokines, as well as environmental stress signals, and is notable for its role in cellular
death [81-83]. However, aside from its role in the initiation of apoptosis, JNK has been
shown to regulate cellular proliferation and differentiation [80-83]. Published reports
suggest that during the later stages of myogenesis, the JNK pathway is severely downregulated [80]. When this pathway is active in satellite cells, differentiation is inhibited
and the satellite cells are able to self-renew or remain in a quiescent state depending on
the context of cellular signaling [80].
Conversely, activation of the p38 MAPK signaling pathway results in a loss of
satellite cell self-renewal [69]. The p38 MAPK signaling pathway is activated in response
to various cytokines and environmental stress signaling and results in a differentiation of
cells or in their apoptotic and autophagic cell death [84-87]. Throughout myogenesis, p38
MAPK signaling is activated and results in cellular differentiation by inducing cells to
withdraw from the cell cycle [88-91]. Previous studies have found that when the JNK
pathway is inhibited, the p38 MAPK pathway is up-regulated [80]. Satellite cells from
aged mice show an up-regulation of the p38 MAPK pathway which may be a reason for
the inhibition of asymmetric division of satellite cells [69].
Recently, the Wnt7a/Fzd7 planar cell polarity pathway (non-canonical Wnt
signaling) has been found to drive the symmetric division of satellite cells to facilitate
regenerative myogenesis [68]. A portion of the satellite cells (i.e. Pax7+/MyoD+) express
the alternative Wnt signaling receptor Frizzled 2 (Fzd7) [68]. In non-canonical Wnt
signaling, Wnt activates the small GTPases Rho and Rac after receptor activation [68].
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Rho and Rac cause a rearrangement of the cytoskeleton that results in a symmetric
division of the satellite cells [92]. Skeletal muscle containing Fzd7-deficient satellite cells
show a marked decrease in regenerative capacity, whereas Fzd7+ satellite cells
demonstrate a robust ability to facilitate regenerative myogenesis [92].
The JAK-STAT signaling pathway causes activation of satellite cells and inhibits
quiescence [71]. In various cell types, JAK/STAT signaling pathway has been shown to
induce proliferation, migration, and differentiation. Prolonged activation of this pathway
also causes cell death through apoptosis [93-97]. When receptors that are associated with
JAK tyrosine kinases are activated, they multimerize as hetero- and homodimers and
activate JAK signaling due to the multimerization bringing JAK proteins into close
proximity [94]. Activation of the JAK proteins causes a phosphorylation of, amongst
other things, the STAT transcription factors [94, 96]. Activated STATs translocate to the
nucleus, dimerize, and then bind to various regulatory sequences to alter transcription of
target genes [97]. Reports have shown that knockdown of Jak2 or Stat3 result in an
increase in the symmetric division of satellite cells and an increase in satellite cell ability
to differentiate and contribute to regenerative myogenesis [71]. Upon activation, Stat3
promotes the differentiation of myoblasts through an up-regulation of MyoD [98]. It has
been previously reported that the satellite cells in skeletal muscle of aged humans’ exhibit
increased expression of various components of JAK-STAT pathway and a concomitant
impediment of satellite cell quiescence [99].

1.6 NF-κB Signaling. NF-κB is a family of proteins consisting of: RelA (p65), RelB, cRel, the canonical NF-κB precursor p105 and spliced form p50, and the non-canonical
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NF-κB precursor p100 and spliced form p52, which form hetero- and homodimers [100].
NF-κB resides in its inactive state in the cytoplasm as a heterotrimer consisting of p50,
p65, and IκBα subunits. On activation of the complex, IκBα sequentially undergoes
phosphorylation, ubiquitination, and degradation, thus releasing the p50-p65 heterodimer
for translocation to the nucleus. NF-κB can be activated by pro-inflammatory signals,
such as TNF-α, leading to the activation of the canonical NF-κB pathway (Figure 1.3)
[100]. In the canonical pathway, inhibitor of κB (IκB) is phosphorylated and degraded by
IκB Kinase subunit-β (IKKβ/IKK2) [101]. Free from IκB, canonical NF-κB p105/p50
translocates to the nucleus where it stimulates gene expression of a wide variety of
molecules [101]. Conversely, NF-κB can be activated in an IKKβ-independent fashion,
termed the alternative or non-canonical NF-κB pathway (Figure 1.3) [100]. In contrast,
activation of the non-canonical NF-κB pathway requires the activation of NF-κBinducing kinase (NIK) and IKKα, leading to the phosphorylation and proteolytic
processing of the p100 subunit to generate p52 [102]. The canonical pathway primarily
utilizes a heterodimer of RelA and p105/p50 [101], whereas the non-canonical pathway
involves the translocation of p52/RelB dimers to the nucleus [102].
TGFβ-activated kinase 1 (TAK1/MAP3K7) is a member of the MitogenActivated Protein Kinase Extracellular Signal-Regulated Kinase (MEK) Kinase family
that activates numerous downstream signaling pathways [103]. TAK1 is normally bound
to accessory protein TAK1-binding protein 1 (TAB1), but upon stimulation, it also
interacts with TAB2 and TAB3 [104]. Pro-inflammatory stimuli activate TAK1 through
activation of several upstream molecules, a process that also involves K63-linked
polyubiquitination [105]. This polyubiquitination is driven by the E2 ligase, Ubc13, or by
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one of the E3 ligases, such as Tumor Necrosis Factor (TNF) Receptor (TNFR)
Associated Factor 6 (TRAF6) [106]. TAB2 and TAB3 have a preferential binding affinity
to K63-linked polyubiquitin chains [106]. Thus, once TAK1 is polyubiquitinated, TAB2
and TAB3 bind leading to the enzymatic activation of TAK1 [106, 107]. Activated TAK1
causes the phosphorylation of several downstream signaling proteins, including IKKβ
that leads to the activation of canonical NF-κB pathway [107].
Activation of TAK1 in response to cellular stress can lead to the initiation of
either anti- or pro-apoptotic signaling cascades [107]. TAK1 activates anti-apoptotic
pathways by signaling to NF-κB and JNK, whereas it will utilize the activation of
caspases to induce pro-apoptotic pathways [107]. Although TAK1 facilitates both a proapoptotic and an anti-apoptotic state, my lab has shown that inactivation of TAK1 leads
to increased oxidative stress and satellite cell death primarily through necroptosis [65].

1.7 NF-κB Signaling in Myogenesis and Skeletal Muscle Pathology. Within the
context of skeletal muscle myogenesis, there is a bit of a dichotomy between the role of
canonical [108] and non-canonical NF-κB signaling [109]. The canonical pathway is
activated in proliferating myoblasts [108]. Indeed, activation of canonical pathways
inhibits differentiation of myoblasts into myotubes [108]. Canonical NF-κB signaling
causes down-regulation of MyoD, which is required to escape proliferation and progress
further into myogenesis [110]. Conversely, the non-canonical NF-κB pathway is active
when myoblasts are starting to undergo fusion to form myotubes [109]. It is also involved
in mitochondrial biogenesis, which allows the growing myotubes to meet their ATP
needs [109]. Forced expression of the canonical NF-κB pathway has been shown to cause
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progressive muscle atrophy [111], whereas an inhibition can lead to a reduction of
inflammatory and fibrotic changes that facilitate muscle repair [112].
The canonical NF-κB pathway has been studied extensively in myoblasts and
myofibers [108, 109, 111, 113-116]. However, the role of canonical NF-κB signaling in
the regulation of satellite cell function during regenerative myogenesis has not been yet
investigated. Recently, the role of a few upstream molecules of the canonical NF-κB
signaling pathway has been investigated in satellite cells [65, 117]. Work from my lab
has shown that TRAF6 plays a critical role during regenerative myogenesis and for the
homeostasis of satellite cells [117]. It was demonstrated that the deletion of TRAF6 in
satellite cells led to a dramatic deficit in skeletal muscle regeneration [117]. TRAF6 is
required for the activation of the JNK1/2 and ERK1/2, which subsequently activate c-Jun
transcription factor [117]. Activated c-Jun binds to the promoter region and induces gene
expression of Pax7. The TRAF6/c-Jun signaling axis also lead to down-regulation of
miR-1 and miR-206, which normally promote the differentiation of myoblasts [117]. My
lab has also shown that TAK1 is critical for satellite cell functionality and maintenance
[65]. Prior work from my lab showed that when TAK1-deficient satellite cells
precociously differentiate and rapidly deplete the satellite cell pool [65]. Further, it was
shown that TAK1 mediates the activation of JNK signaling, which is necessary to prevent
precocious differentiation of the satellite cell pool and to prevent oxidative stress [65].
Although not specifically the focus of my thesis, the canonical NF-κB signaling
pathway is involved in a multitude of muscle pathologies and age-related changes
associated with skeletal muscle [118]. It has been shown that NF-κB signaling is
activated in various inflammatory myopathies, such as Duchenne muscular dystrophy,
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polymyositis, and dermatomyositis [119]. The general trend in these myopathies is that
the canonical NF-κB signaling pathway is over-activated, which exacerbates the
inflammation associated with these conditions and increases cellular oxidative stress
[119, 120]. In certain alveolar rhabdomyosarcoma substrains, the canonical NF-κB-YY1miR-29 signaling axis is disturbed [121]. Along similar lines, the age associated muscle
wasting, or sarcopenia, has been shown to be partially mediated by increased activation
of the canonical NF-κB signaling pathway [111].
Ultimately, the specific role of canonical NF-κB signaling in satellite cells
remains poorly studied. Within the context of regenerative myogenesis, the role of
canonical NF-κB signaling in satellite cells is completely unknown. Thusly, we sought to
investigate the role of canonical NF-κB signaling in satellite cells. The experiments
detailed in this thesis work to further our understating of: NF-κB signaling, satellite cell
homeostasis, and the process of muscle regeneration. Through the generation of: an
inducible satellite cell-specific IKKβ knockout mouse, an inducible satellite cell-specific
IKKβ overexpression mouse, and a concurrent inducible satellite cell-specific TAK1
knockout-IKKβ overexpression mouse, here we investigate the role of canonical NF-κB
signaling in satellite cell proliferation, differentiation, and survival during regenerative
myogenesis. Our results demonstrate that tight regulation of IKKβ is essential for the
proliferative and regenerative capabilities of satellite cells, both in vivo and in vitro.

17

FIGURE 1.1
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Figure 1.1 Myogenesis. Schematic representation of the process of myogenesis.
Myogenic regulatory factors orchestrate the progression from the pluripotent stem cell
state to the adult myofiber. Pax7 is a marker for the early myogenic stem cells and
progenitors. Myf-5 is the first MRF to be activated, and is followed sequentially by
MyoD, Myogenin, and MRF4. Eventually, myosin heavy chain, a marker of mature
skeletal muscle, begins to be expressed.
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FIGURE 1.2
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Figure 1.2 Satellite cell activation post-injury. Schematic representation of satellite cell
activation following skeletal muscle injury. Satellite cells get activated and begin to
express MyoD, leading to their proliferation through symmetric cell division. Eventually,
through hierarchical MRF signaling, the satellite cells differentiate and then fuse with the
regenerating myofibers. Alternatively, the satellite cells down-regulate MyoD and
undergo asymmetric cell division to self-renew their stem cell population and then return
to quiescence.
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FIGURE 1.3
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Figure 1.3 Canonical and non-canonical NF-κB signaling. Schematic representation of
the two NF-κB signaling pathways. Activation can occur through the canonical or noncanonical pathways. Pro-inflammatory signaling leads to the activation of the TAK1
signalosome. TAK1 in turn activates IKKβ, leading to the phosphorylation and
degradation of IκBs. This leads to the nuclear translocation of p50/65 dimer. The noncanonical pathway involves the activation of NIK which causes the phosphorylation of
IKKα. Subsequently, IKKα causes the phosphorylation and proteolytic processing of
p100, generating p52 protein which then make a complex with RelB and translocate to
the nucleus to induce gene expression of specific molecules. .
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CHAPTER 2

SATELLITE CELL-SPECIFIC ABLATION OF IKKβ RESULTS IN AN IMPAIRED
REGENERATIVE PROCESS

2.1 Introduction. Skeletal muscle is composed of multinucleated myofibers, which
themselves arise from the fusion of myoblasts during embryonic development [122].
Although adult skeletal muscle is a post-mitotic tissue, it has a remarkable ability to
regenerate in response to traumatic injury or strenuous exercise. Skeletal muscle
regeneration is mediated by a subset of adult stem cells, termed satellite cells, which are
located between the basal lamina and the sarcolemma in a relatively dormant state [122,
123]. Upon muscle injury, satellite cells enter the cell cycle, undergo several rounds of
cell division, and then differentiate into myoblasts, which ultimately fuse with each other
or with injured myofibers to complete the repair process. While a vast majority of
satellite cells commit to the myogenic lineage, a fraction of them self-renews and returns
to quiescence to replenish the satellite cell pool [124]. Satellite cells express the
transcription factor paired box 7 (Pax7), which is essential for their self-renewal,
proliferation, and maintenance of myogenic potential in adult skeletal muscle. The role of
Pax7 in satellite cell homeostasis is evidenced by the findings that the targeted ablation of
Pax7 results in the depletion of the satellite cell pool and impairment of skeletal muscle
regeneration after traumatic injury [125, 126].
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Nuclear factor-κB (NF-κB) is a family of transcription factors, which regulate a
large number of genes involved in survival, proliferation, and differentiation of both
immune and non-immune cell types [127]. The NF-κB family contains five members:
RelA (also known as p65), RelB, c-Rel, p105/p50, and p100/p52, which make homo- and
heterodimers. In unstimulated cells, NF-κB proteins are normally sequestered in the
cytoplasm by the related family member Inhibitor of κB (IκB) and the IκB Kinase (IKK)
complex [128]. NF-κB can be activated through either the canonical or non-canonical
pathway [127]. The canonical NF-κB signaling pathway involves the upstream activation
of IKKβ and subsequent phosphorylation and degradation of IκB proteins, resulting in
rapid and transient nuclear translocation of canonical NF-κB members, predominantly the
p50/RelA and p50/c-Rel dimers. In the non-canonical pathway, a central signaling
molecule is NF-κB-inducing kinase (NIK), which activates and cooperates with IKKα to
mediate p100 phosphorylation, which in turn leads to p100 ubiquitination and
degradation of its C-terminal IκB-like structure, resulting in the generation of mature NFκB2 (i.e. p52) and nuclear translocation of the non-canonical NF-κB complex p52/RelB
[128]. Published reports suggest that the activation of NF-κB reduces skeletal muscle
mass, metabolic function, and regeneration especially in disuse conditions and chronic
disease states [129-131]. Intriguingly, a recent study has demonstrated that sustained
inhibition of NF-κB in myofibers increases the age-associated loss of skeletal muscle
mass suggesting that physiological levels of NF-κB are essential to maintaining skeletal
muscle health [132].
Studies using cultured myoblasts have suggested that the canonical and noncanonical NF-κB pathways play distinct roles in the regulation of myogenesis [133]. The
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canonical NF-κB pathway is activated in proliferating myoblasts, but is inhibited during
the differentiation of myoblasts into multinucleated myotubes [133]. Indeed, several
proinflammatory cytokines inhibit myogenic differentiation through the activation of
canonical NF-κB signaling [134, 135]. In contrast, the non-canonical NF-κB pathway
becomes activated during myogenic differentiation and promotes mitochondrial
biogenesis [136, 137]. Moreover, activation of the non-canonical NF-κB signaling
pathway promotes myoblast fusion during myogenesis [138, 139].
While the role of IKKβ-mediated canonical NF-κB signaling in the regulation of
myogenesis is evidenced, it remains enigmatic whether this pathway has any role in the
regulation of satellite stem cell function. It has been reported that the activation of IKKβ
in satellite cells is a reason for their reduced differentiation into the myogenic lineage in
mouse models of cancer cachexia [116]. In contrast, we found that the proinflammatory
cytokine, TWEAK, activates NF-κB in satellite cells. Interestingly, inhibition of
canonical NF-κB signaling improves the number of Pax7+ cells in TWEAK-treated
cultures suggesting that depending on the stimuli, the activation of NF-κB can
differentially regulate the fate of satellite cells [140]. Recent studies from our group have
shown that TAK1 and TRAF6, the upstream regulators of the canonical NF-κB signaling
pathway, are essential for the survival, self-renewal, and proliferation of satellite cells in
skeletal muscle of adult mice. Targeted ablation of either TAK1 or TRAF6 in satellite
cells severely impairs skeletal muscle regeneration in adult mice [65, 117]. However, the
role of canonical NF-κB signaling in the regulation of satellite cell function during
regenerative myogenesis has not yet been investigated.
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In this study, through the generation of an inducible satellite cell-specific IKKβ
knockout (KO) mouse, we demonstrate that the canonical NF-κB signaling pathway in
satellite cells is essential for the proper regeneration of skeletal muscle after injury. Our
results also suggest that the canonical NF-κB pathway promotes survival and
proliferation of satellite cells. In addition, we demonstrate that canonical NF-κB
signaling is essential to prevent precocious differentiation of activated satellite cells.

2.2 Materials and methods.
Animals. Satellite cell-specific inducible IKKβ-knockout mice (i.e. P7:IKKβ-KO) were
generating by crossing Pax7-CreER (Jax Strain: B6.Cg-Pax7tm1(cre/ERT2)Gaka/J) with floxed
IKKβ (i.e. IKKβf/f) mice. All mice were in the C57BL/6J background and their genotype
was determined by PCR from tail DNA. For Cre-mediated inducible deletion of IKKβ, 6week and 12-week old mice were injected intraperitoneally (i.p.) with Tamoxifen (10 mg
per Kg body weight) for five consecutive days. Control mice were injected with corn oil
only. The Institutional Animal Care and Use Committee (IACUC) and Institutional
Biosafety Committee (IBC) of the University of Louisville approved all experimental
protocols with mice in advance.

Skeletal muscle injury. One week after the first injection of tamoxifen, 100µL of 1.2%
Barium Chloride (BaCl2, Sigma Chemical Co.) in saline was injected into the tibialis
anterior (TA) muscle of mice to induce necrotic muscle injury. At various time points,
TA muscle was collected from euthanized mice for biochemical and histological studies.

27

Myoblast fusion. To study myoblast fusion, two days following BaCl2-mediated necrotic
muscle injury in the TA, mice were given an i.p. injection of 5-ethnyl-2’-deoxyuridine
(EdU; 4 µg per gm body weight). Twelve days post-EdU injection, the TA was isolated
and transverse muscle sections made. The sections were subsequently immunostained
with anti-Laminin, DAPI for the detection of nuclei, and processed for the detection of
+

EdU. The number of interstitial and intramyofibrillar EdU myonuclei per myofiber was
quantified using NIH ImageJ software.

Histology and morphometric analysis. For skeletal muscle morphology and
regeneration assessment, 10 µm-thick transverse sections of the TA were stained with
Hematoxylin and Eosin. For quantitative analysis, CSA, minimum Feret’s diameter, and
multinucleation were analyzed in H&E stained TA muscle sections. H&E slides were
mounted using DPX Mountant For Histology Slide mounting medium (Sigma Chemical
Co.) and visualized at room temperature on a Nikon Eclipse TE 2000-U Microscope
(Nikon), a digital camera (Nikon Digital Sight DS-Fi1), and Nikon NIS Elements BR
3.00 software (Nikon). Exposure time was kept at 80ms and contrast levels were not
altered.

Satellite cell cultures. Satellite cells were isolated from the hind limbs of 6- to 8-weekold C57BL/6J mice as described [117]. For siRNA experiments, cells were transfected
using the RNAiMAX Lipofectamine system using a protocol from the manufacturer.
Control siRNA-A (cat# sc-37007), mouse NF-κB p65 siRNA (cat# sc-29411), and mouse
IKK beta siRNA (cat# sc-35645) were obtained from Santa Cruz Biotechnology. For

28

overexpression plasmid studies, cells were transfected using the Neon Electroporation
transfection system using a protocol from the manufacturer with settings of: 1500V,
10ms pulse width, for three pulses. pCMV4 p65 was a gift from Warner Greene
(Addgene plasmid # 21966) [141]. pcDNA-Ikkb-FLAG WT was a gift from Warner
Greene (Addgene plasmid # 23298) [142]. pcDNA3.1 (Invitrogen) was used as a control
for the pCMV4 p65 and pcDNA-Ikkb-FLAG WT plasmids.

Isolation and culturing of myofibers. Single myofiber cultures were established from
extensor digitorum longus (EDL) muscle after digestion with collagenase II (Worthington
Biochemical Corporation, Lakewood, NJ) and trituration as previously described [117].
Suspended myofibers were collected immediately or cultured in 60 mm horse serumcoated plates in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with: 10%
fetal bovine serum (FBS; Invitrogen), 2% chicken embryo extract (Accurate Chemical,
Westbury, NY), 10 ng/mL basic fibroblast growth factor (Peprotech, Rocky Hill, NJ),
and 1% penicillin-streptomycin for three days.

Immunofluorescence. For IHC and ICC studies, frozen TA muscle sections (9 or 10 µmthick sections) or myoblast/myofiber cultures, respectively, were fixed in 4%
paraformaldehyde (PFA) in phosphate buffered saline (PBS), blocked in 2% bovine
serum albumin (BSA) in PBS for one hour, and subsequently incubated with anti-Pax7
(1:5-1:10, DSHB Cat# pax7, RRID:AB_528428), anti-eMyHC (1:200, DSHB Cat#
F1.652, RRID:AB_447163), anti-MyoD (1:200, Santa Cruz Biotechnology Cat# sc-304,
RRID:AB_631992), anti-Laminin (1:150, Cell Signaling Technology Cat# L9393,

29

RRID:AB_477163), or anti-p-p65 (1:100, Cell Signaling Technology Cat# 3033,
RRID:AB_331284) in blocking solution at 4°C overnight under humidified conditions.
The sections were washed briefly with PBS before incubation with its respective
secondary antibody for one hour at room temperature and then washed three times for
five minutes with PBS. Nuclei were visualized by counterstaining with DAPI for five
minutes. Refer to Appendix-3 for complete antibody listing.

EdU and TUNEL Staining. To determine the proliferation status of satellite cells, EdU
staining was performed using a commercially available kit and following the protocol
from the manufacturer (Click-iT EdU Cell Proliferation Assay kit, Invitrogen). Briefly,
during the last 90 minutes of incubation, 10 µM EdU (Invitrogen) was added in culture
medium. The cells were fixed in 4% PFA. EdU visualization occurs through a click
reaction, whereby the EdU is covalently bonded to a fluorescent label (Alexa Fluor® 488
Azide). Nuclei were visualized by counterstaining with DAPI for 5 minutes. TUNEL
staining was performed following a protocol from the manufacturer (in situ Cell Death
Detection Kit, Sigma Aldrich). Briefly, the sections or myofiber cultures were fixed in
4% PFA and permeabilized with 0.1% Triton X-100 in 0.1% sodium citrate, and then
incubated in TUNEL reaction mixture for 60 minutes at 37°C.

Fluorescent Imaging. ICC/IHC slides were mounted using Aqua-Poly/Mount
fluorescence medium (Polysciences, Inc) and visualized at -0.4°C on a Nikon TiE 3000
Inverted Microscope (Nikon), a digital camera (DXM-1200C Coded Digital Camera),
and Nikon NIS Elements AR software (Nikon). Image levels were equally adjusted using

30

Adobe Photoshop CS6 software (Adobe). Detailed specifications, exposure times, and
contrast levels provided in Appendix-4.

Western blot. Relative levels of various proteins were quantified by performing Western
blot as described [65]. Briefly, skeletal muscle of mice or cultured myoblasts was washed
with PBS, homogenized in lysis buffer (50 mM Tris-Cl (pH 8.0), 200 mM NaCl, 50 mM
NaF, 1 mM dithiothreitol, 1 mM sodium orthovanadate, 0.3% IGEPAL, and Protease
Inhibitor Cocktail). Approximately, 100 µg of protein was resolved on each lane on a
10% SDS-PAGE, electro-transferred onto a nitrocellulose membrane and probed using
various primary antibodies. Detection of proteins was enhanced by chemiluminescence;
refer to Appendix-3 for list of proteins. As a loading control, membranes were stripped
and re-probed with anti-GAPDH (1:2000, Cell Signaling Technology Cat# 2218,
RRID:AB_561053).

RNA isolation and quantitative Real-time PCR (qRT-PCR) Assay. RNA isolation
and qRT-PCR were performed as previously described [117]. Total RNA was extracted
from skeletal muscle tissue of mice or cultured myogenic cells using the TRIzol reagent
(Thermo Fisher Scientific Life Sciences) and an RNeasy Mini Kit (Qiagen, Valencia,
CA, USA) according to the manufacturers’ protocols. First-strand cDNA for PCR
analyses were generated with a commercially available kit (Thermo Fisher Scientific Life
Sciences). Quantification of mRNA expression was performed using the SYBR Green
dye (Thermo Fisher Scientific Life Sciences) method on a sequence-detection system
(model 7300; Thermo Fisher Scientific Life Sciences). Approximately 25 µl of reaction
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volume was used for the real-time PCR assays which consisted of 2× (12.5 µl) Brilliant
SYBR Green QPCR Master Mix (Stratagene), 400 nm of primers (0.5 µl each from the
stock), 11 µl of water, and 0.5 µl of template. The thermal conditions consisted of an
initial denaturation at 95 °C for 10 min followed by 40 cycles of denaturation at 95 °C for
15 s, annealing and extension at 60 °C for 1 min, and, for a final step, a melting curve of
95 °C for 15 s, 60 °C for 15 s, and 95 °C for 15 s. All reactions were carried out in
triplicate to reduce variation. Primers were designed using Vector NTI software (Thermo
Fisher Scientific Life Sciences). The sequences of the primers used are as follows: βactin, 5’-CAG GCA TTG CTG ACA GGA TG-3’ (forward) and 5’-TGC TGA TCC
ACA TCT GCT GG-3’ (reverse); IFN-γ, 5’-GAC AAT CAG GCC ATC AGC AAC-3’
(Forward), 5’-CGG ATG AGC TCA TTG AAT GCT T-3’; IL-1β, 5’-CTC CAT GAG
CTT TGT ACA AGG-3’ (Forward), 5’-TGC TGA TGT ACC AGT TGG GG-3’
(Reverse); IL-6, 5’-ATG GCA ATT CTG ATT GTA TG -3’ (Forward), 5’-TGG CTT
TGT CTT TCT TGT TA-3’ (Reverse); Pax7, 5’-CAG TGT GCC ATC TAC CCA TGC
TTA-3’ (Forward), 5’-GGT GCT TGG TTC AAA TTG AGC C-3’ (Reverse); Myf5, 5’TGA AGG ATG GAC ATG ACG GAC G-3’ (Forward), 5’-TTG TGT GCT CCG AAG
GCT GCT A-3’ (Reverse); Myh3, 5’-ACA TCT CTA TGC CAC CTT CGC TAC-3’
(Forward), 5’-GGG TCT TGG TTT CGT TGG GTA T-3’ (Reverse); Myh4, 5’-CGG
CAA TGA GTA CGT CAC CAA A-3’ (Forward), 5’-TCA AAG CCA GCG ATG TCC
AA-3’ (Reverse); MyoD, 5’-TGG GAT ATG GAG CTT CTA TCG C-3’ (Forward), 5’GGT GAG TCG AAA CAC GGA TCA T-3’ (Reverse); Myogenin, 5’-CAT CCA GTA
CAT TGA GCG CCT A-3’ (Forward), 5’-GAG CAA ATG ATC TCC TGG GTT G-3’
(Reverse); and TNF-α, 5’-AGC ACA GAA AGC ATG ATC CG-3’ (Forward), 5’-GCC
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ACA AGC AGG AAT GAG AA-3’ (Reverse). The data were analyzed using SDS
software version 2.0, and the results were exported to Microsoft Excel for further
analysis. Data normalization was accomplished using two endogenous control (β-actin)
and the normalized values were subjected to a 2-ΔΔCt formula to calculate the fold change
between the control and experimental groups. The formula and its derivations were
obtained from the ABI Prism 7900 Sequence Detection System user guide.

Lactate dehydrogenase (LDH) assay. The amount of LDH in culture supernatants was
measured using a commercially available LDH Cytotoxicity Assay kit following the
protocol suggested by the manufacturer (Thermo Scientific Life Sciences).

Statistical analyses. For the sake of transparency, results were expressed as box-andwhisker plots with the box comprised of the 1st, 2nd, and 3rd quartiles, and the lower and
upper whiskers corresponding to the minimum and maximum values, respectively, to
display the entire range of data. Statistical analyses between two groups used unpaired
two-tailed Student’s t-test to compare quantitative data populations with normal
distribution and equal variance. A value of p<0.05 was considered statistically significant
unless specified otherwise for comparisons made between two groups.

2.3 Results
2.3.1 Canonical NF-κB signaling is activated in satellite cells after skeletal muscle
injury. We first investigated how the levels of different components of canonical NF-κB
pathway are regulated in skeletal muscle upon injury. Tibialis anterior (TA) muscle of
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12-week old wild-type (WT) mice was injured by intramuscular injection of 1.2% BaCl2
solution, whereas the contralateral muscle was injected with saline alone and served as an
uninjured control. At day 5 after injury, the muscle was collected and analyzed by
performing immunoblotting or immunohistochemical analysis. There was a noticeable
increase in the levels of IKKβ in 5d-injured TA muscle compared to contralateral
uninjured muscle. Moreover, the levels of phosphorylated, as well as total, IκBα and p65
proteins were considerably increased in injured muscle compared to uninjured controls
(Figure 2.1A). To understand whether muscle injury leads to the activation of canonical
NF-κB signaling in satellite cells, we performed double immunostaining for phospho-p65
(p-p65) and Pax7 (a marker for satellite cells) proteins. Consistent with a published report
[143], p-p65 protein was undetectable in satellite cells of uninjured muscle, however, the
expression of p-p65 protein was clearly visible in Pax7+ cells in injured muscle (Figure
2.1B).
A suspension culture of myofiber explants represents an ex vivo model that
mimics muscle injury in vivo, with respect to satellite cell survival, activation,
proliferation, and differentiation [117, 144, 145]. To further understand whether
canonical NF-κB signaling is activated in satellite cells upon injury, we established single
myofiber cultures from extensor digitorum longus (EDL) muscle of WT mice and
myofiber-associated satellite cells were examined for the expression of p-p65 protein at
different time points. We could not detect p-p65 protein in satellite cells (i.e. Pax7+) just
after isolation of myofibers (Figure 2.1C). Interestingly, a gradual increase in p-p65
levels in Pax7+ cells was evidenced at 24h and 72h after establishing the cultures (Figure
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2.1C). These results suggest that muscle injury leads to the activation of canonical NFκB signaling in satellite cells of adult mice.

2.3.2 Satellite cell-specific deletion of IKKβ delays myofiber regeneration in adult
mice. In response to various cytokines, growth factors, and microbial products, the
activation of the canonical NF-κB pathway involves the stimulation of IKKβ [127]. To
understand the role of canonical NF-κB signaling in the regulation of satellite cell
homeostasis and function, we crossed floxed IKKβ (IKKβf/f) mice that are homozygous
for loxP sites flanking Exon 3 with Pax7-CreER mice (a tamoxifen-inducible satellite
cell-specific Cre line) [146] to generate satellite cell-specific inducible IKKβ-knockout
(IKKβf/f; Pax7-CreER) mice (Figure 2.2A). Since Pax7-CreER mice are knock-in mice
in which the expression of Pax7 is regulated by the endogenous Pax7 promoter, we used
adult IKKβf/f;Pax7-CreER mice and treated them with tamoxifen or vehicle (corn oil)
alone to generate satellite cell-specific IKKβ knockout (henceforth P7:IKKβ-KO) or
control (Ctrl) mice, respectively. The mice were subjected to five intraperitoneal
injections of tamoxifen or vehicle (Figure 2.2B). One week after the first injection of
tamoxifen, TA muscle of Ctrl and P7:IKKβ-KO mice was injected with 100 µl of 1.2%
BaCl2 solution unilaterally to induce necrotic muscle injury, whereas the contralateral
muscle was injected with saline and served as an uninjured control. The uninjured and
injured TA muscles were isolated at 5d and 14d post-injury and analyzed by performing
Hematoxylin and Eosin (H&E) staining (Figure 2.2C). Under naïve conditions, we found
no statistically significant difference in the average cross-sectional area (CSA) or
minimal Feret’s diameter between P7:IKKβ-KO and littermate Ctrl mice (data not
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shown). Interestingly, we found that the regeneration of TA muscle was considerably
diminished in P7:IKKβ-KO mice compared to littermate Ctrl mice at 5d post BaCl2mediated injury. Morphometric analysis of 5d-injured TA muscle sections showed an
approximate 40% reduction in average myofiber CSA in P7:IKKβ-KO mice compared to
littermate Ctrl mice (Figure 2.2D). Additionally, a significant reduction in the average
minimal Feret’s diameter of myofibers was noticeable in 5d-indured TA muscle of
P7:IKKβ-KO mice compared to littermate Ctrl mice (Figure 2.2E). Newly formed,
centrally multinucleated myofibers populated the regenerating TA muscle of Ctrl mice.
However, the P7:IKKβ-KO mice showed a marked decrease in centrally multinucleated
myofibers compared to littermate Ctrl mice, indicating further signs of an impaired
regeneration (Figure 2.2F). Although muscle structure appeared comparable, a
significant reduction in average myofiber CSA and a trend towards reduction in minimal
Feret’s diameter (p=0.08) was noticeable in TA muscle of P7:IKKβ-KO mice compared
to littermate Ctrl mice even after 14d of injury (Figure 2.2G, 2.2H). For some of our
initial experiments, 12-week old littermate IKKβf/f and IKKβf/f; Pax7-CreER mice were
treated by i.p. injections of tamoxifen similar to as described above (Figure 2.2B). TA
muscle of these mice was injured and muscle regeneration was studied at day 5 postinjury by performing H&E staining (data not shown). Similar to the above results, we
found that the muscle regeneration was reduced in IKKβf/f; Pax7-CreER mice compared
to IKKβf/f mice suggesting that the deletion of IKKβ in satellite cells reduces the
regeneration of skeletal muscle, whereas the treatment of tamoxifen itself does not (data
not shown).
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2.3.3 Targeted inactivation of IKKβ diminishes the number of nascent myofibers
and satellite cells in regenerating muscle of adult mice. To further confirm that the
deletion of IKKβ in satellite cells reduces myofiber regeneration, we also examined the
number of myofibers expressing the embryonic isoform of myosin heavy chain
(eMyHC). Consistent with the notion that eMyHC is expressed in newly found
myofibers, we did not find any eMyHC+ myofibers in uninjured TA muscle of Ctrl or
P7:IKKβ-KO mice. By contrast, the number of eMyHC+ myofibers was dramatically
increased in 5d-injured TA muscle. However, the frequency of eMyHC+ myofibers
within laminin staining (Figure 2.3B) and the size of eMyHC+ myofibers (Figure 2.3C,
2.3D) were significantly reduced in TA muscle of P7:IKKβ-KO mice compared with
corresponding Ctrl mice.
We next investigated the effect of deletion of IKKβ on satellite cell number. TA
muscle of Ctrl and P7:IKKβ-KO mice were immunostained for Pax7 and Laminin
proteins. Nuclei were labeled by staining with DAPI (Figure 2.3E). There was no
significant difference in the number of Pax7+ positive cells in uninjured TA muscle of
Ctrl and P7:IKKβ-KO mice (data not shown). Interestingly, we found that the number of
Pax7+ cells was significantly reduced in 5d-injured TA muscle of P7:IKKβ-KO mice
compared to littermate Ctrl mice (Figure 2.3E, 2.3F). Furthermore, mRNA levels of
Pax7 were found to be significantly reduced in 5d-injured TA muscle of P7:IKKβ-KO
mice compared to littermate Ctrl mice (Figure 2.3G). These results suggest that the
deletion of IKKβ reduces satellite cell number following injury, which may be
responsible for the delayed myofiber regeneration.
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Activation of canonical NF-κB signaling leads to the expression of a number of
inflammatory cytokines [127, 128]. However, it remains unknown whether satellite cells
are also the source of inflammatory molecules in injured skeletal muscle. Nevertheless,
by performing qRT-PCR, we measured relative mRNA levels of proinflammatory
cytokines: interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α). There was no
significant difference in the mRNA levels of these cytokines in 5d-injured TA muscle of
Ctrl and P7:IKKβ-KO mice (Figure 2.3H), suggesting that the deletion of IKKβ in
satellite cells does not affect the expression of inflammatory cytokines.

2.3.4 Inhibition of canonical NF-κB signaling reduces the proliferation of satellite
cells. To understand cellular mechanisms for the reduced number of satellite cells in
regenerating skeletal muscle of P7:IKKβ-KO mice, we investigated the role of canonical
NF-κB signaling in the proliferation of satellite cells in vivo, ex vivo, and in vitro. TA
muscle of 12-week old Ctrl and P7:IKKβ-KO mice was injured by intramuscular
injection of 1.2% BaCl2 solution. After 48h, the mice were given an intraperitoneal
injection of EdU and the number of EdU+ nuclei in the TA muscle was determined 12
days later. Interestingly, a significant reduction in both intramyofibrillar and interstitial
EdU+ nuclei was observed in TA muscle of P7:IKKβ-KO mice compared with
corresponding Ctrl mice (Figure 2.4A, 2.4B). To further understand whether IKKβ
regulates the proliferation of satellite cells, we established myofiber explant cultures and
the proliferation of myofiber-associated cells were studied by measuring EdU
incorporation after 72h of culturing. Consistent with our in vivo results, we found that the
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proportion of EdU+ nuclei was significantly reduced in myofiber explants prepared from
P7:IKKβ-KO mice compared to Ctrl mice (Figure 2.4C, 2.4D).
We also investigated the role of canonical NF-κB signaling in the proliferation of
satellite cell-derived myogenic cultures in a myofiber-free system. For this experiment,
primary myogenic cultures established from WT mice were transfected with scrambled
(control), IKKβ, or p65 siRNA. After 72h, cellular proliferation was studied by
performing an EdU incorporation assay. Results showed that the knockdown of IKKβ
and p65 significantly reduced the proportion of EdU+ nuclei in myogenic cultures
(Figure 2.4E, 2.4F). Our Western blot analysis also showed that the levels of cyclin D1
and cyclin A were significantly reduced in cultures transfected with IKKβ siRNA or p65
siRNA compared to control cultures (Figure 2.4G). Western blot analysis confirmed a
drastic reduction in IKKβ and p65 protein upon transfection with their corresponding
siRNAs (Figure 2.4G).

2.3.5 Canonical NF-κB signaling promotes the survival of satellite cells. One of the
important functions of the canonical arm of NF-κB signaling is to promote cell survival
[127, 128]. Our attempts to perform double immunostaining for TUNEL and Pax7 were
futile, possibly because the levels of Pax7 are reduced in satellite cells undergoing
apoptosis. Therefore, we employed ex vivo myofiber explants and cultured myogenic
cells to understand the role of the canonical arm of NF-κB signaling in the survival of
satellite cells. We first established myofiber explant cultures from EDL muscle of Ctrl
and P7:IKKβ-KO mice. After 72h of culturing, the percentage of apoptotic cells was
measured by performing TUNEL staining. Interestingly, the proportion of myofiber-
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associated TUNEL+ cells was significantly higher in P7:IKKβ-KO cultures compared to
Ctrl cultures (Figure 2.5A, 2.5B).
We next investigated the effect of siRNA-mediated knockdown of IKKβ or p65
on survival of cultured primary myogenic cells. Lactate dehydrogenase (LDH) is a stable
enzyme that accumulates in culture supernatants after cell death [147]. Interestingly, we
found that the levels of LDH in culture supernatants of cells transfected with IKKβ and
p65 siRNA were significantly higher compared to those transfected with control siRNA
(Figure 2.5C). We also performed Annexin V/propidium iodide (PI) staining on these
cells followed by analysis using FACS. Similar to our LDH results, we found that the
percentages of early and late apoptotic cells were significantly increased in cultures
transfected with IKKβ and p65 siRNA compared to those transfected with scrambled
siRNA (Figure 2.5D-F). We also performed Western blotting to measure the levels of
cleaved Caspase-3 and cleaved PARP, two established markers of apoptosis. As shown in
Figure 2.5G, the levels of cleaved PARP were significantly increased in cultures
transfected with IKKβ or p65 siRNA compared to those transfected with scrambled
siRNA. Moreover, we found that the knockdown of IKKβ or p65 led to a reduction in
levels of BAX and Bcl2 protein in cultured myogenic cells (Figure 2.5G). Collectively,
these results suggest that canonical NF-κB signaling promotes the survival of myogenic
cells.

2.3.6 Canonical NF-κB signaling promotes the self-renewal and prevents the
precocious differentiation of activated satellite cells. Pax7 determines satellite cell fate
in cooperation with other factors, such as MyoD [117, 144, 147]. Indeed, the expression
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pattern of Pax7 and MyoD specifies the myogenic status of satellite cells as quiescent
(Pax7+/MyoD-), activated (Pax7+/MyoD+), or differentiated (Pax7-/MyoD+). We
investigated whether IKKβ has any role in the regulation of satellite cell fate. To model
the satellite cell dynamics of muscle injury, we generated ex vivo suspension cultures of
EDL myofibers from P7:IKKβ-KO and Ctrl mice. The ex vivo suspension cultures were
analyzed by staining with anti-Pax7 and anti-MyoD at 0h or 72h of culturing (Figure
2.6A, 2.6B). There was no significant difference in the number of myofiber-associated
Pax7+ cells between Ctrl and P7:IKKβ-KO cultures at 0h (Figure 2.6A, 2.6C). There
were a negligible number of myofiber-associated MyoD+ cells and there was no
significant difference in their number between Ctrl and P7:IKKβ-KO cultures (Figure
2.6D). Myofiber-associated satellite cells formed clusters by 72h of culturing. Although
there was no significant difference in the average number of clusters per myofiber, the
average number of cells per cluster was significantly reduced in P7:IKKβ -KO cultures
compared to Ctrl cultures (Figure 2.6E). Our analysis also showed that the proportion of
Pax7+/MyoD-, as well as Pax7+/MyoD+, cells was significantly reduced in P7:IKKβ-KO
cultures compared to Ctrl cultures (Figure 2.6F, 2.6G). Conversely, the percentage of
Pax7-/MyoD+ was dramatically increased in P7:IKKβ-KO compared with Ctrl cultures
(Figure 2.6H), suggesting that the inactivation of IKKβ causes a precocious
differentiation of activated satellite cells.
We also investigated the role of canonical NF-κB signaling in the regulation of
satellite cell fate in a myofiber-free environment. We first established satellite cellderived primary myogenic cultures from hind limb muscles of WT mice. Early passage
myogenic cells were transfected with scrambled (control), IKKβ, or p65 siRNA. After
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72h, the cultures were fixed followed by staining with anti-Pax7 and anti-MyoD. Nuclei
were labeled using DAPI (Figure 2.7A). Consistent with published reports [117, 147],
we found that the majority of cells were Pax7+/MyoD+, whereas a small proportion were
Pax7+/MyoD- in cultures transfected with control siRNA. Although there was a trend
towards reduction in the percentage of Pax7+/MyoD- cells in cultures transfected with
IKKβ or p65 siRNA, it was not significantly different from those transfected with control
siRNA (Figure 2.7B). However, the proportion of Pax7+/MyoD+ cells was significantly
reduced, whereas the proportion of Pax7-/MyoD+ cells was significantly increased in
IKKβ or p65 knocked-down cultures compared to control cultures (Figure 2.7C, 2.7D).
By performing immunostaining for myosin heavy chain (MyHC) protein, we also
investigated whether the knockdown of IKKβ or p65 can induce the terminal
differentiation of satellite cell-derived myoblasts under growth conditions. There was a
negligible number of MyHC+ cells in myogenic cultures transfected with scrambled or
IKKβ siRNA (Figure 2.7E). Intriguingly, we found that the knockdown of p65 increased
the number of MyHC+ cells. Consistent with our immunocytochemistry results,
immunoblotting showed that the levels of Pax7 were somewhat reduced, whereas levels
of myogenin and MyHC were increased especially in cultures transfected with p65
siRNA (Figure 2.7F).

2.4 Discussion. Satellite cells normally exist in a quiescent state [123], but are rapidly
activated following injury to skeletal muscle [35]. Similar to other stem cells, satellite
cells possess the ability to self-renew and maintain a reserve pool in healthy tissue, such
that they can facilitate several episodes of regeneration [17, 33, 35]. Diminishing the
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satellite cell pool is associated with an impairment in regenerative myogenesis and can
lead to muscle wasting normally observed in genetic muscle disorders and during aging
[148-150]. NF-κB plays a critical role in the regulation of cell fate, survival, and
differentiation in both immune and non-immune cell types [127, 151]. Activation of NFκB also leads to an inflammatory response, especially in chronic disease states [127,
128]. While components of the canonical NF-κB pathway have been found to be
activated in myofibers in various catabolic states, as well as in both myogenic and
inflammatory immune cells in muscle degenerative disorders [113, 129, 152], the
physiological role of NF-κB in the regulation of satellite cell function remains less
understood. Our results in the present study demonstrate that canonical NF-κB signaling
mediated by IKKβ and p65 promotes the survival, proliferation, and self-renewal of
satellite cells.
Skeletal muscle regeneration is a complex process that is regulated by signals
released from both damaged myofibers, as well as several other cell types that are either
resident in the muscle or recruited to assist in clearing cellular debris [122, 123].
Activation of satellite cells upon muscle injury requires transcriptional and translational
reprogramming that is essential for their exit from quiescence, proliferation, and survival
in a metabolically activate state [124, 153-155]. Our results demonstrate that the
activation of the canonical arm of the NF-κB pathways is increased in the satellite cells
upon skeletal muscle injury (Figure 2.1). This activation of NF-κB appears to be a
mechanism to improve the proliferation and survival of satellite cells, evidenced by the
finding that both the proliferation (Figure 2.4) and survival (Figure 2.5) of satellite cells
is diminished upon genetic or siRNA-mediated knockdown of the components of the
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canonical NF-κB pathway. NF-κB is known to induce cellular proliferation through
augmenting the expression of a number of growth regulatory molecules and cell cycle
regulators [127, 129]. Indeed, previous studies have shown that NF-κB promotes
myogenic cell proliferation through increasing the expression of cyclin D1 [156].
Similarly, NF-κB is known to induce the expression of several anti-apoptotic molecules,
such as Bcl2 [127, 128]. Our results demonstrate that the levels of both Cyclin D1 and
Bcl2 were diminished upon knockdown of either IKKβ or p65 in cultured satellite cells
(Figure 2.4G, 2.5G). Reduced proliferation and/or increased cell death through apoptosis
appear to be important mechanisms for the reduced number of satellite cells observed in
regenerating skeletal muscle of P7:IKKβ-KO mice.
For efficient regeneration of skeletal muscle, satellite cells have to undergo
extensive proliferation before their differentiation and fusion with injured myofibers.
Premature differentiation or defects in the process of differentiation of satellite cells into
the myogenic lineage can lead to deficits in skeletal muscle regeneration. Although the
molecular mechanisms remain unknown, recent studies have suggested that NF-κB may
play a role in the regulation of satellite cell self-renewal and differentiation. It has been
reported that in the “settings” of cancer cachexia, the ability of satellite cells to
differentiate into the myogenic lineage is lost, which may be a mechanism for cancerinduced muscle wasting [116]. Interestingly, the activation of the canonical arm of NFκB signaling has been found to be one of the reasons for deregulation of Pax7 expression
and satellite cell dysfunction in tumor-bearing mice [116]. However, the role of canonical
NF-κB signaling in the self-renewal of satellite cell in naïve conditions or during
regenerative myogenesis remains unknown.
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We found no significant difference in the number of quiescent/self-renewing
(Pax7+/MyoD-) satellite cells in skeletal muscle of Ctrl and IKKβ-KO mice in uninjured
muscle, suggesting that the inhibition of canonical NF-κB signaling does not disrupt
satellite cell homeostasis in naïve conditions. Interestingly, our results demonstrate that
the inhibition of canonical NF-κB signaling reduces the proliferation of activated satellite
cells and causes their premature differentiation (Figures 2.6 and 2.7). While previous
studies have shown that constitutive activation of canonical NF-κB signaling inhibits
myogenic differentiation [129, 133], the results of the present study suggest that NF-κB
signaling is essential to support the proliferation of activated satellite cells. It is important
to note that while knockdown of IKKβ reduced the number of proliferating
(Pax7+/MyoD+) and increased the number of differentiating (Pax7-/MyoD+) cells, it was
not sufficient to induce terminal differentiation of satellite cells. By contrast, knockdown
of p65 also resulted in the expression of MyHC, a marker of terminal differentiation of
myogenic cells. This could be attributed to the fact that in addition to IKKβ, the p65
subunit of NF-κB can also be activated through signaling cross-talk and post-translational
modifications [127]. Moreover, since p65 is the main subunit of the canonical NF-κB
complex with transactivation domain, its knockdown may lead to a complete blockade of
canonical NF-κB signaling. Indeed, our experiments demonstrate that compared to IKKβ,
knockdown of p65 has more pronounced effects on proliferation, differentiation, and
survival of cultured satellite cells (Figures 2.4, 2.5, and 2.7). On similar lines, a previous
study has demonstrated that muscle-derived stem cells (MDSCs) from p65+/– mice show
increased differentiation potential compared to those isolated from littermate WT mice
[157].

45

The role of NF-κB in skeletal muscle regeneration has been previously
investigated using genetic mouse models and molecular and pharmacological approaches
[129, 158]. NF-κB is highly activated in dystrophic muscle of Mdx (a mouse model of
DMD) mice [113, 159]. Interestingly, the genetic ablation of IKKβ in myofibers or in
macrophages improved myopathy observed in Mdx mice [113]. Similarly,
pharmacological inhibition of NF-κB using NEMO binding domain peptide was effective
in improving muscle pathogenesis in Mdx mice [113, 160]. Another study showed that
the genetic ablation of IKKβ in myofibers improves skeletal muscle strength and
regeneration, and inhibits the accumulation of fibrosis in otherwise normal mice [131].
On similar lines, we have demonstrated that the inhibition of TRAF6 in myofibers
improves skeletal muscle regeneration potentially through inhibition of NF-κB [144].
However, all of these studies were performed using mice in which the components of
canonical NF-κB signaling were inhibited in myofibers and the improvement in muscle
regeneration was attributed to a reduction in the inflammatory milieu in the injured
muscle microenvironment. Our present study demonstrates that canonical NF-κB
signaling is important for satellite cell homeostasis and function during skeletal muscle
regeneration. These finding are also supported by our recently published articles
demonstrating that the targeted ablation of TRAF6 or TAK1, the upstream activator of
IKKβ, also inhibits satellite stem cell homeostasis and function [117, 147]. A more
dramatic effect of satellite cell-specific ablation of TAK1 or TRAF6 compared to IKKβ
on regenerative myogenesis could be attributed to the fact that, being upstream signaling
modules, TAK1 and TRAF6 can regulate other pathways, including MAPKs, which are
also implicated in the regulation of satellite cell fate and function [117, 147, 161].
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In summary, our study provides initial evidence that canonical NF-κB signaling
promotes the proliferation and survival of satellite cells. Furthermore, we provide
evidence that satellite cell expression of IKKβ is important for the successful
regeneration of adult skeletal muscle. An exhaustion of satellite cells is common in
several muscular disorders and conditions, both in actual number, as well as functional
satellite cells [162]. However, it remains to be elucidated whether a reduction in NF-κB is
responsible for satellite cell dysfunction in disease conditions. It will be interesting to
investigate whether there is differential regulation of canonical NF-κB signaling in
satellite cells and myofibers in different physiological and pathological conditions.
Indeed, other myogenic pathologies, such as rhabdomyosarcoma, demonstrate aberrations
in the canonical NF-κB signaling pathway [121]. Further studies into differential
expressions of the canonical NF-κB signaling pathway may pave the road for novel
therapies for pathological conditions involving skeletal muscle.
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FIGURE 2.1
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FIGURE 2.1 Canonical NF-κB signaling is activated during regenerative
myogenesis. TA muscle of 12-week old WT mice was injected with 100 µl of 1.2%
BaCl2 while the other side was injected with saline to serve as the uninjured control (A)
Representative Immunoblots demonstrating the levels of: IKKβ, phospho- and total IκBα
and p65, and unrelated protein GAPDH in uninjured and 5-day injured TA muscle. (B) In
a separate experiment, muscles were collected and processed for histological analysis.
Representative photomicrographs of Pax7 and anti-phospho-p65 stained muscle sections
from uninjured and injured TA muscle of WT mice. Nuclei were identified by staining
with DAPI. Arrowheads point to Pax7+/phospho-p65- cells. Arrows point to
Pax7+/phospho-p65+ cells. Scale bar, 20 µm. (D) Representative photomicrographs of
EDL single myofiber suspension cultures at 0, 24, and 72h incubation in growth medium
after immunostaining for Pax7 and phospho-p65. Nuclei were identified by staining with
DAPI. Scale bar, 10 µm.
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FIGURE 2.2
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FIGURE 2.2 Satellite cell-specific deletion of IKKβ impairs muscle regeneration in
adult mice. (A) Schematic representation of the breeding strategy used for the generation
of satellite cell-specific IKKβ-knockout mice. (B) Treatment protocol for tamoxifeninduced Cre recombination and subsequent muscle collection in P7:IKKβ-KO and Ctrl
mice. (C) Representative photomicrographs of H&E-stained sections illustrating a
regeneration defect in injured TA muscle of P7:IKKβ-KO compared with littermate Ctrl
mice at indicated time points after BaCl2 injection. Scale bars: 20 µm. Quantification of
(D) average myofiber CSA, (E) average minimal Feret’s diameter, and (F) percentage of
myofibers containing two or more centrally located nuclei per field at day 5 post-injury.
N=5. Quantification of (G) average CSA and (H) minimal Feret’s diameter at day 14
post-injury. N=3 (Ctrl), 4 (P7:IKKβ-KO). *P<0.05, **P<0.01, ***P<0.001 values
significantly different from corresponding TA muscle of Ctrl mice by unpaired two-tailed
t-test.
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FIGURE 2.3
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FIGURE 2.3 Inactivation of IKKβ in satellite cells impedes the formation of new
myofibers and diminishes the satellite cell pool. (A) Representative photomicrograph
of five day injured transverse TA muscle section of Ctrl and P7:IKKβ-KO 12-week old
mice after immunostaining for eMyHC and Laminin. Nuclei were identified by staining
with DAPI. Scale bar, 20 µm. Quantification of (B) percentage of eMyHC+ myofibers per
Laminin+ myofiber, (C) average CSA of eMyHC+ myofiber, and (D) average minimal
Feret’s diameter of eMyHC+ myofiber in five day injured P7:IKKβ-KO and Ctrl mice.
(E) Representative photomicrograph of five day injured transverse TA muscle section of
Ctrl and P7:IKKβ-KO mice after immunostaining for Pax7 and Laminin. Nuclei were
identified by staining with DAPI. Arrowhead points to Pax7+ cells. Scale bar, 20 µm. (F)
Quantification of number of Pax7+ cells per Laminin+ myofiber. N=5. (G) Relative
mRNA levels of Pax7 in 5 day injured TA muscle of P7:IKKβ-KO and Ctrl mice. (H)
Relative mRNA levels of select inflammatory markers in 5 day injured TA muscle of
P7:IKKβ-KO and Ctrl mice. N=4. *P<0.05, **P<0.01, ***P<0.001 values significantly
different from corresponding TA muscle of Ctrl mice by unpaired two-tailed t-test.
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FIGURE 2.4
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FIGURE 2.4 Inactivation of IKKβ in satellite cells diminishes satellite cell
proliferation. TA muscle of P7:IKKβ-KO and Ctrl mice was injured by intramuscular
injection of 100 µl of 1.2% BaCl2 solution. After 2 days, the mice were given an
intraperitoneal injection of EdU and 12 days later TA muscles were collected and muscle
sections prepared were stained to detect EdU, laminin, and nuclei. (A) Representative
photomicrograph of 14 day injured transverse TA muscle section of Ctrl and P7:IKKβKO mice after processing for EdU and Laminin detection. Nuclei were identified by
staining with DAPI. Arrowhead points to interstitial EdU+ nuclei. Arrow points to
intramyofibrillar EdU+ nuclei. Scale bar, 20 µm. (B) Quantification of interstitial EdU+
and intramyofibrillar EdU+ nuclei per Laminin+ myofiber in TA muscle of Ctrl and
P7:IKKβ-KO mice. N=4 (Ctrl), 3 (P7:IKKβ-KO). Single myofibers cultures were
established from EDL muscle of Ctrl and P7:IKKβ-KO mice and cultured for 72h. For
last 90 min, the cells were pulse labeled with EdU by addition of EdU in culture medium.
The myofibers cultures were then fixed with paraformaldehyde and stained for EdU.
Nuclei were labeled by incubation in DAPI. (C) Representative merged images of EdU
and DAPI staining are presented here. Scale bar, 10 µm. (D) Quantification of percentage
of EdU+ cells per cluster. Cluster was defined as ≥4 cells. N=3 mice, 9-11 fibers per
group. Primary WT myoblasts were transfected with scrambled siRNA or siRNA
targeting IKKβ or p65 for 72h. (E) Representative photomicrograph of siRNA
transfected cells after processing for EdU detection. Nuclei were identified by staining
with DAPI. Scale bar, 10 µm. (F) Quantification of percent EdU+ cells. N=4. (G) In a
similar experiment, cells were collected after 48h of siRNA transfection and processed
for biochemical analysis. Immunoblots represented here demonstrate the protein levels of
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Cyclin D1, Cyclin A, IKKβ, p65, and unrelated protein GAPDH as a loading control.
N=3. *P<0.05, **P<0.01, ***P<0.001 values significantly different from corresponding
TA muscle of Control mice by unpaired two-tailed t-test. $P<0.05, values significantly
different from scrambled siRNA control by unpaired two-tailed t-test.
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FIGURE 2.5
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FIGURE 2.5 Satellite cell-specific ablation of IKKβ causes an increase in apoptotic
cell death. (A) Single myofiber suspension cultures were established from EDL muscle
of 6-week old P7:IKKβ-KO and Ctrl mice, and cultured for 72h then processed for
detection of TUNEL. Nuclei were identified by staining with DAPI. Scale bar, 10 µm.
(B) Quantification of percentage of TUNEL+ cells per cluster. Cluster was defined as ≥4
cells. N=3 mice, 9-11 fibers per group. Primary WT myoblasts were transfected with
scrambled siRNA or siRNA targeting IKKβ or p65 for 48h (C) Quantification of relative
LDH activity (fold change) following siRNA transfection. (D) Following siRNA
transfection, cells were collected and stained for Annexin V and propidium iodide (PI),
and analyzed by FACS to detect early and late apoptotic cells. Quantification of (E) early
(lower right quadrant) apoptotic cells and (F) late (upper right quadrant) apoptotic cells
following siRNA transfection. (G) Immunoblots demonstrating the levels of cell death –
related proteins: BAX, Bcl2, Cleaved-Caspase3, Cleaved PARP and unrelated protein
GAPDH. N=3. *P<0.05, values significantly different from Scrambled siRNA transfected
cells by unpaired two-tailed t-test. $P<0.05, values significantly different from scrambled
siRNA control by unpaired two-tailed t-test. $$P<0.01, values significantly different from
scrambled siRNA control by unpaired two-tailed t-test. $$$P<0.001, values significantly
different from scrambled siRNA control by unpaired two-tailed t-test.
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FIGURE 2.6
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FIGURE 2.6 Satellite cell-specific deletion of IKKβ diminishes the self-renewal of
satellite cells and results in their premature differentiation. Single myofiber
suspension cultures were established from EDL muscle of 6-week old P7:IKKβ-KO and
Ctrl mice, and cultured for 0 or 72 hours then collected and immunostained for Pax7 and
MyoD. Representative individual and merged images of (A) freshly isolated and (B) 72h
cultured myofibers from Ctrl and P7:IKKβ-KO mice stained with PAX7, MyoD, and
DAPI. Quantification of (C) Pax7+ cells per myofiber and (D) MyoD+ cells per myofiber
in Ctrl and P7:IKKβ-KO 0-hour cultures. Quantification of (E) average number of cells
per cluster, (F) percentage of Pax7+/MyoD- cells per cluster, (G) percentage of
Pax7+/MyoD+ cells per cluster, and (H) percentage of Pax7-/MyoD+ cells per cluster in
Ctrl and P7:IKKβ-KO 72-hour cultures. Cluster was defined as ≥4 cells. N=3 mice, 9-11
fibers per group. Data presented as box-and-whisker plot. *P<0.05, **P<0.01,
***P<0.001 values significantly different from Ctrl mice by unpaired two-tailed t-test.
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FIGURE 2.7
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FIGURE 2.7 Inhibition of IKKβ causes a precocious differentiation and inhibition
of p65 results in an early terminal differentiation. Primary WT myoblasts were
transfected with scrambled siRNA or siRNA targeting IKKβ or p65 for 72h (A)
Representative photomicrograph of siRNA transfected cells after immunostaining for
Pax7 and MyoD. Nuclei were identified by staining with DAPI. Quantification of (B)
percentage of Pax7+/MyoD- cells, (C) percentage of Pax7+/MyoD+ cells, and (D)
percentage of Pax7-/MyoD+ cells post-siRNA transfection. N=3. (E) Representative
photomicrograph of siRNA transfected cells after immunostaining for MyHC. Nuclei
were identified by staining with DAPI. In a similar experiment, WT myoblasts were
transfected with scrambled siRNA or siRNA targeting IKKb or p65 for 48h. (F)
Representative Immunoblots showing protein levels of Pax7, MyoD, Myogenin, MyHC,
and unrelated protein Tubulin as a loading control. $P<0.05, values significantly different
from scrambled siRNA control by unpaired two-tailed t-test. @P<0.05, values
significantly different from IKKβ siRNA transfected group by unpaired two-tailed t-test.
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CHAPTER 3

SATELLITE CELL-SPECIFIC OVEREXPRESSION OF A CONSTITUTIVELY
ACTIVE MUTANT OF IKKβ HINDERS MUSCLE REGENERATION

3.1 Introduction. Skeletal muscle is composed of myofibers which themselves arise
from fusion of hundreds of myoblasts during embryological development [122]. Skeletal
muscle has the ability to repair itself, which is attributed to the presence of a satellite
stem cell population [23]. Following myofiber injury, several cell types are recruited at
the site of injury to assist in the restoration of skeletal muscle structure [23]. While a few
other cell types have been suggested to commit to myogenic fate, satellite cells are the
main cell type that ensures skeletal muscle regeneration. Upon activation, these cells
proliferate, differentiate, and eventually fuse to injured myofibers to accomplish repair
[24]. Moreover, a small proportion of activated satellite cells return to a quiescent state
and replenish the satellite cell pool in freshly regenerated muscle [124]. Pax7
transcription factor is essential for maintaining the stemness of satellite cells and their
function during regenerative myogenesis [125, 126].
Nuclear Factor-κB (NF-κB) family proteins are expressed in both immune and
non-immune cell types [100]. As mentioned in previous chapters, the canonical NF-κB
pathway involves upstream activation of IKKβ, which causes phosphorylation of IκBα
protein. Phosphorylated IκBα protein is subsequently degraded through the proteasome
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[100, 101]. Free from IκB, canonical NF-κB dimers (i.e. p50/p65) translocate to the
nucleus and orchestrate gene expression of several molecules involved in cellular
survival, proliferation, and differentiation [101]. The canonical pathway promotes
proliferation, but inhibits their differentiation into multinucleated myotubes [108, 110].
By contrast, activation of the non-canonical NF-κB pathway requires upstream activation
of NIK and IKKα [100]. IKKα facilitates the proteolytic processing of p100 into the p52
subunit, which then forms a complex with RelB. The p52/RelB complex eventually
translocates to the nucleus to facilitate transcription of target genes [102]. Recent studies
have suggested that the non-canonical NF-κB pathway promotes myoblast fusion. In
addition, this pathway promotes mitochondrial biogenesis to improve the maintenance of
the differentiated phenotype of myotubes [109].
Under naïve conditions, mature skeletal muscle exhibits a relatively low activity
of the canonical NF-κB pathway. However, various components of this pathway have
been reported to be upregulated in diseased skeletal muscle [119]. Indeed, inflammatory
changes and an increase in oxidative stress in various skeletal muscle myopathies have
been directly associated with heightened activation of canonical NF-κB signaling [119,
120]. Sarcopenia, or muscle wasting associated with age, has also been shown to be
partially mediated by an increased activation of the canonical NF-κB signaling cascade
[111]. Furthermore, in a multitude of rhabdomyosarcoma substrains, primarily the
alveolar subtype, the canonical NF-κB-YY1-miR-29 signaling axis is disrupted [121].
The miR-29 normally acts as a tumor suppressor, but due to the over-activation of the
canonical NF-κB signaling pathway, miR-29 signaling is silenced leading to
uncontrollable cell growth [121].
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As such, modulating the activity of NF-κB signaling has been an experimental
means of combating muscle pathology. In the Mdx mouse model of Duchenne muscular
dystrophy, single allele deletion of NF-κB subunit p65/RelA was sufficient to reduce the
infiltration of macrophages, myofiber necrosis, and calcification and improve the
regeneration of injured myofibers in dystrophic muscle [160]. Similar results were also
obtained upon shRNA-mediated knockdown of RelA or through the overexpression of a
dominant negative mutant of IKKβ using adeno-associated virus (AAV) in skeletal
muscle of Mdx mice [112]. Furthermore, targeted depletion of IKKβ in macrophages or
mature myofibers also considerably reduced the expression of inflammatory cytokines
and ameliorated the dystrophic phenotype in Mdx mice [113]. Consistently, muscle
regeneration was also improved in WT mice lacking RelA or IKKβ in skeletal muscle
following cardiotoxin mediated injury, as evidenced by increased numbers of centrally
located nuclei and increased diameter of regenerating myofibers [102].
However, most of the investigations about the role of canonical NF-κB signaling
in myopathy or myofiber regeneration have been carried out through modulating the
levels of components of NF-κB in mature skeletal muscle or the inflammatory immune
cells. A recent report has also suggested that an increase in NF-κB activity in satellite
cells is also associated with age-associated defects in muscle repair [111]. While the role
of canonical NF-κB signaling has become increasingly evidenced in the regulation of
myogenesis, its role in satellite stem cell function remains less understood. Previous
reports have shown that satellite cell activation of IKKβ results in a reduced
differentiation through the myogenic lineage in select mouse models of cancer cachexia
[116]. Work from our lab has shown that TWEAK, a pro-inflammatory cytokine,
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activates the canonical NF-κB pathway in satellite cells and that the inhibition of this
pathway in TWEAK treated cultures resulted in an increase in the number of Pax7+ cells
[140]. These studies and others indicate that depending on the cellular context or the
stimulus, activation of the canonical NF-κB signaling pathway results in a differential
regulation of satellite cell fate.
Having derived from Chapter 2 that the satellite cell-specific depletion of IKKβ
resulted in a decrease in muscle regeneration in mice, we next sought to investigate the
effect of overexpression of IKKβ in satellite cells because of the signaling paradigm’s
close association with various skeletal muscle pathologies. Our results demonstrate that
overexpression of a constitutively active mutant of IKKβ in satellite cells diminishes
skeletal muscle regeneration following injury. IKKβ overexpressing satellite cells exhibit
a precocious differentiation phenotype, but retain an intact self-renewal potential. We
further report that forced activation of the canonical NF-κB pathway diminishes satellite
cell proliferation and results in increased cell death. Thus, the results from the current
study, coupled with our findings from the previous chapter, indicate that strict levels of
canonical NF-κB signaling are necessitated for the proper functioning of satellite cells.

3.2 Materials and methods.
Animals. Satellite cell-specific inducible constitutive active (ca) IKKβ (i.e. P7:IKKβca)
were generating by crossing Pax7-CreER with R26-Stop floxed IKK2ca mice (Jax Strain:
B6(Cg)-Gt(ROSA)26Sortm4(Ikbkb)Rsky/J). All mice were in the C57BL/6J background and
their genotype was determined by PCR from tail DNA. For Cre-mediated inducible
overexpression of IKKβ, 6-week and 12-week old mice were injected i.p. with
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Tamoxifen (10 mg per Kg body weight) for five consecutive days. Control mice were
injected with corn oil only. The IACUC and IBC of the University of Louisville approved
all experimental protocols with mice in advance.

Skeletal muscle injury. One week after the first injection of tamoxifen, 100µL of 1.2%
BaCl2 (Sigma Chemical Co.) in saline was injected into the TA muscle of mice to induce
necrotic muscle injury. At various time points, TA muscle was collected from euthanized
mice for biochemical and histological studies.

Myoblast fusion. To study myoblast fusion, two days following BaCl2-mediated necrotic
muscle injury in the TA, mice were given an i.p. injection of 5-ethnyl-2’-deoxyuridine
(EdU; 4 µg per gm body weight). Twelve days post-EdU injection, the TA was isolated
and transverse muscle sections made. The sections were subsequently immunostained
with anti-Laminin, DAPI for the detection of nuclei, and processed for the detection of
+

EdU. The number of interstitial and intramyofibrillar EdU myonuclei per myofiber was
quantified using NIH ImageJ software.

Histology and morphometric analysis. For skeletal muscle morphology and
regeneration assessment, 10 µm-thick transverse sections of the TA were stained with
Hematoxylin and Eosin. For quantitative analysis, CSA, minimum Feret’s diameter, and
multinucleation were analyzed in H&E stained TA muscle sections. H&E slides were
mounted using DPX Mountant For Histology Slide mounting medium (Sigma Chemical
Co.) and visualized at room temperature on a Nikon Eclipse TE 2000-U Microscope
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(Nikon), a digital camera (Nikon Digital Sight DS-Fi1), and Nikon NIS Elements BR
3.00 software (Nikon). Exposure time was kept at 80ms and contrast levels were not
altered.

Satellite cell cultures. Satellite cells were isolated from the hind limbs of 6- to 8-weekold C57BL/6J mice as described [117]. For overexpression plasmid studies, cells were
transfected using the Neon Electroporation transfection system using a protocol from the
manufacturer with settings of: 1500V, 10ms pulse width, for three pulses. pCMV4 p65
was a gift from Warner Greene (Addgene plasmid # 21966) [141]. pcDNA-IKKβ-FLAG
WT was a gift from Warner Greene (Addgene plasmid # 23298) [142]. pcDNA3.1
(Invitrogen) was used as a control for the pCMV4 p65 and pcDNA-IKKβ-FLAG WT
plasmids.

Isolation and culturing of myofibers. Single myofiber cultures were established from
EDL muscle after digestion with collagenase II (Worthington Biochemical Corporation,
Lakewood, NJ) and trituration as previously described [117]. Suspended myofibers were
collected immediately or cultured in 60 mm horse serum-coated plates in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with: 10% fetal bovine serum (FBS;
Invitrogen), 2% chicken embryo extract (Accurate Chemical, Westbury, NY), 10 ng/mL
basic fibroblast growth factor (Peprotech, Rocky Hill, NJ), and 1% penicillinstreptomycin for three days.
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Immunofluorescence. For IHC and ICC studies, frozen TA muscle sections (9 or 10 µmthick sections) or myoblast cultures, respectively, were fixed in 4% paraformaldehyde
(PFA) in phosphate buffered saline (PBS), blocked in 2% bovine serum albumin (BSA)
in PBS for one hour, and subsequently incubated with anti-Pax7 (1:5-1:10, DSHB Cat#
pax7, RRID:AB_528428), anti-eMyHC (1:200, DSHB Cat# F1.652, RRID:AB_447163),
anti-MyoD (1:200, Santa Cruz Biotechnology Cat# sc-304, RRID:AB_631992), antiLaminin (1:150, Cell Signaling Technology Cat# L9393, RRID:AB_477163), or anti-pp65 (1:100, Cell Signaling Technology Cat# 3033, RRID:AB_331284) in blocking
solution at 4°C overnight under humidified conditions. The sections were washed briefly
with PBS before incubation with respective secondary antibody for one hour at room
temperature and then washed three times for five minutes with PBS. Nuclei were
visualized by counterstaining with DAPI for five minutes. Refer to Appendix-3 for
complete antibody listing.

EdU and TUNEL Staining. To determine the proliferation status of satellite cells, EdU
staining was performed using a commercially available kit and following the protocol
from the manufacturer (Click-iT EdU Cell Proliferation Assay kit, Invitrogen). Briefly,
during the last 90 minutes of incubation, 10 µM EdU (Invitrogen) was added in culture
medium. The cells were fixed in 4% PFA. EdU visualization occurs through a click
reaction, whereby the EdU is covalently bonded to a fluorescent label (Alexa Fluor® 488
Azide). Nuclei were visualized by counterstaining with DAPI for 5 minutes. TUNEL
staining was performed following a protocol from the manufacturer (in situ Cell Death
Detection Kit, Sigma Chemical Co.). Briefly, the sections or myofiber cultures were fixed
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in 4% PFA and permeabilized with 0.1% Triton X-100 in 0.1% sodium citrate, and then
incubated in TUNEL reaction mixture for 60 minutes at 37°C.

Fluorescent Imaging. ICC/IHC slides were mounted using Aqua-Poly/Mount
fluorescence medium (Polysciences, Inc) and visualized at -0.4°C on a Nikon TiE 3000
Inverted Microscope (Nikon), a digital camera (DXM-1200C Coded Digital Camera),
and Nikon NIS Elements AR software (Nikon). Image levels were equally adjusted using
Adobe Photoshop CS6 software (Adobe). Detailed specifications, exposure times, and
contrast levels provided in Appendix-4.

RNA isolation and quantitative Real-time PCR (qRT-PCR) Assay. RNA isolation
and qRT-PCR were performed as previously described [117]. Total RNA was extracted
from skeletal muscle tissue of mice or cultured myogenic cells using the TRIzol reagent
(Thermo Fisher Scientific Life Sciences) and an RNeasy Mini Kit (Qiagen, Valencia,
CA, USA) according to the manufacturers’ protocols. First-strand cDNA for PCR
analyses were generated with a commercially available kit (Thermo Fisher Scientific Life
Sciences). Quantification of mRNA expression was performed using the SYBR Green
dye (Thermo Fisher Scientific Life Sciences) method on a sequence-detection system
(model 7300; Thermo Fisher Scientific Life Sciences). Approximately 25 µl of reaction
volume was used for the real-time PCR assays which consisted of 2× (12.5 µl) Brilliant
SYBR Green QPCR Master Mix (Stratagene), 400 nm of primers (0.5 µl each from the
stock), 11 µl of water, and 0.5 µl of template. The thermal conditions consisted of an
initial denaturation at 95 °C for 10 min followed by 40 cycles of denaturation at 95 °C for
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15 s, annealing and extension at 60 °C for 1 min, and, for a final step, a melting curve of
95 °C for 15 s, 60 °C for 15 s, and 95 °C for 15 s. All reactions were carried out in
triplicate to reduce variation. Primers were designed using Vector NTI software (Thermo
Fisher Scientific Life Sciences). The sequences of the primers used are as follows: βactin, 5’-CAG GCA TTG CTG ACA GGA TG-3’ (forward) and 5’-TGC TGA TCC
ACA TCT GCT GG-3’ (reverse); IFN-γ, 5’-GAC AAT CAG GCC ATC AGC AAC-3’
(Forward), 5’-CGG ATG AGC TCA TTG AAT GCT T-3’; IL-1β, 5’-CTC CAT GAG
CTT TGT ACA AGG-3’ (Forward), 5’-TGC TGA TGT ACC AGT TGG GG-3’
(Reverse); IL-6, 5’-ATG GCA ATT CTG ATT GTA TG -3’ (Forward), 5’-TGG CTT
TGT CTT TCT TGT TA-3’ (Reverse); Pax7, 5’-CAG TGT GCC ATC TAC CCA TGC
TTA-3’ (Forward), 5’-GGT GCT TGG TTC AAA TTG AGC C-3’ (Reverse); Myf5, 5’TGA AGG ATG GAC ATG ACG GAC G-3’ (Forward), 5’-TTG TGT GCT CCG AAG
GCT GCT A-3’ (Reverse); Myh3, 5’-ACA TCT CTA TGC CAC CTT CGC TAC-3’
(Forward), 5’-GGG TCT TGG TTT CGT TGG GTA T-3’ (Reverse); Myh4, 5’-CGG
CAA TGA GTA CGT CAC CAA A-3’ (Forward), 5’-TCA AAG CCA GCG ATG TCC
AA-3’ (Reverse); MyoD, 5’-TGG GAT ATG GAG CTT CTA TCG C-3’ (Forward), 5’GGT GAG TCG AAA CAC GGA TCA T-3’ (Reverse); Myogenin, 5’-CAT CCA GTA
CAT TGA GCG CCT A-3’ (Forward), 5’-GAG CAA ATG ATC TCC TGG GTT G-3’
(Reverse); and TNF-α, 5’-AGC ACA GAA AGC ATG ATC CG-3’ (Forward), 5’-GCC
ACA AGC AGG AAT GAG AA-3’ (Reverse). The data were analyzed using SDS
software version 2.0, and the results were exported to Microsoft Excel for further
analysis. Data normalization was accomplished using two endogenous control (β-actin)
and the normalized values were subjected to a 2-ΔΔCt formula to calculate the fold change
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between the control and experimental groups. The formula and its derivations were
obtained from the ABI Prism 7900 Sequence Detection System user guide.

Statistical analyses. For the sake of transparency, results were expressed as box-andwhisker plots with the box comprised of the 1st, 2nd, and 3rd quartiles, and the lower and
upper whiskers corresponding to the minimum and maximum values, respectively, to
display the entire range of data. Statistical analyses between two groups used unpaired
two-tailed Student’s t-test to compare quantitative data populations with normal
distribution and equal variance. A value of p<0.05 was considered statistically significant
unless specified otherwise for comparisons made between two groups.

3.3 Results
3.3.1 Constitutive activation of canonical NF-κB signaling in satellite cells attenuates
skeletal muscle regeneration. Our preceding results in Chapter 2 showed that the
inhibition of canonical NF-κB signaling diminishes the regeneration of skeletal muscle in
adult mice. However, there are also reports suggesting that the activation of the canonical
NF-κB pathway, especially in disease conditions, reduces skeletal muscle regeneration
[116, 129]. To specifically investigate the effect of heightened canonical NF-κB
signaling in satellite cell function during muscle regeneration, we employed
R26StopFLIKK2ca (henceforth Rosa26-IKKβca) mice that allow for the inducible
expression of a constitutively active form of IKKβ (IKKβca) and subsequent activation of
the canonical NF-κB pathway (Figure 3.1A) [163]. Rosa26-IKKβca mice were crossed
with Pax7-CreER mice to generate Rosa26-IKKβca;Pax7-CreER mice. To induce the
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expression of IKKβca in satellite cells, Rosa26-IKKβca;Pax7-CreER mice were treated
with tamoxifen or vehicle (corn oil) alone to generate satellite cell-specific IKKβ
overexpression (henceforth P7:IKKβca) or control (Ctrl) mice, respectively (Figure 3.1B
Overexpression of IKKβ in satellite cells of P7:IKKβca mice was confirmed through
immunohistochemical staining of IKKβ protein (Figure 3.1C). Next, TA muscle of Ctrl
and P7:IKKβca mice was injured unilaterally by intramuscular injection of 1.2% BaCl2
solution and muscle regeneration was evaluated at day 5 or day 14 by performing H&E
staining (Figure 3.2A). There was no significant difference in myofiber size in uninjured
TA muscle of Ctrl and P7:IKKβca mice (Figure 3.2B, 3.2C). Interestingly, we found that
the average myofiber CSA, as well as minimal Feret’s diameter, were significantly
reduced in TA muscle of P7:IKKβca mice compared with corresponding Ctrl mice
(Figure 3.2D, 3.2E). Moreover, the proportion of myofibers containing two or more
centrally located nuclei was also significantly reduced in 5d-injured TA muscle of
P7:IKKβca mice compared with Ctrl mice (Figure 3.2F). However, after 14d of injury,
muscle structure was restored in both genotypes, as the average myofiber CSA and
minimal Feret’s diameter were comparable between Ctrl and P7:IKKβca mice (Figure
3.2G, 3.2H). Collectively, these results suggest that constitutive activation of canonical
NF-κB signaling in satellite cells delays muscle regeneration.

3.3.2 Overexpression of IKKβ in satellite cells impedes the formation of new
myofibers. To further examine the effect of IKKβ overexpression in satellite cell
mediated muscle regeneration, we analyzed the proportion of myofibers expressing the
embryonic isoform of myosin heavy chain (eMyHC). We did not find any myofibers
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expressing eMyHC in uninjured TA muscle of Ctrl or P7:IKKβca mice; consistent with
the aforementioned notion that eMyHC is only expressed in newly generated myofibers
(data not shown). Regenerating TA muscle from both groups was populated with newly
formed eMyHC+ myofibers 5 days following injury. (Figure 3.3A). However, the
proportion of eMyHC+ myofibers within the Laminin immunostaining was significantly
reduced in the P7:IKKβca mice compared to littermate Ctrl mice (Figure 3.3B).
Furthermore, the size of the eMyHC+ myofibers, measured by the CSA and minimal
Feret’s diameter, was significantly reduced in regenerating muscle of P7:IKKβca mice
compared to Ctrl mice (Figure 3.3C, 3.3D).
We next investigated whether satellite cell-specific overexpression of IKKβ has
any effect on the proportion of Pax7 expressing satellite cells. Uninjured and 5-day
injured TA muscle of P7:IKKβca and Ctrl mice were double immunostained for Pax7 and
Laminin. Nuclei were counterstained with DAPI (Figure 3.3E). Under naïve-uninjured
conditions, we found no significant changes in the number of satellite cells, evidenced by
comparable levels of Pax7 between the two groups (data not shown). Interestingly, the
number of satellite cells was significantly reduced in the TA muscle of 5d-injured
P7:IKKβca compared to that of Ctrl littermate mice (Figure 3.3F). Consistently, we
found a significant reduction in the mRNA levels of Pax7 in 5d-injured TA muscle of
P7:IKKβca compared to littermate Ctrl mice (Figure 3.3G). Altogether, these findings
indicate that the overexpression of a constitutively active mutant of IKKβ dimnishes the
pool of activated satellite cells following necrotic muscle injury.
Activation of the canonical NF-κB pathway has been shown to induce the
expression of various proinflammatory cytokines [127, 128]. However, it remains to be
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elucidated whether satellite cells are a source of inflammatory molecules during
regenerative myogenesis. In an effort to investigate their possible involvement, we
measured the transcript levels of the proinflammatory cytokines: Interleukin (IL)-1β, IL6, and Interferon-γ (IFN-γ) via qRT-PCR. We found a significant reduction in the relative
mRNA levels of all three proinflammatory cytokines in the 5 day injured TA muscle of
P7:IKKβca compared to littermate Ctrl mice (Figure 3.3H), suggesting that the
overexpression of IKKβ in satellite cells negatively regulates the expression of certain
inflammatory cytokines in the context of regenerative myogenesis. IL-1β is a known
activator of canonical NF-κB signaling and IL-6 has been shown to differentially regulate
the canonical NF-κB signaling depending on cellular context [101, 164-166]. It is within
the realm of possibility that heightened activation of NF-κB signaling in satellite cells
results in feedback inhibition of its potential activators/mediators (i.e. IL-1β and IL-6) in
an attempt to blunt the hyperactivated pathway.

3.3.3 Overexpression of IKKβ in satellite cells leads to a reduction in satellite cell
proliferation. To understand the cellular mechanisms for the reduction in satellite cells
in skeletal muscle undergoing regeneration in P7:IKKβca mice, we investigated the role
of supra-physiological activation of canonical NF-κB signaling in the proliferation of
satellite cells in vivo, ex vivo, and in vitro. TA muscle of 12-week old Ctrl and
P7:IKKβca mice was injured unilaterally by intramuscular injection of 1.2% BaCl2
solution. Forty-eight hours later, the mice were given an i.p. injection of EdU. Twelve
days later, corresponding to 14 days post-injury, we investigated the number of EdU
incorporating nuclei in the TA muscle (Figure 3.4A). Interestingly, we observed a
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significant reduction in both the interstitial and intramyofibrillar EdU+ nuclei in TA
muscle of P7:IKKβca mice compared with corresponding Ctrl mice (Figure 3.4B, 3.4C).
To further understand whether supra-physiological IKKβ-mediated NF-κB signaling
specifically affects the proliferation of satellite cells, we generated myofiber explant
cultures and measured changes in the proliferation of myofiber-associated satellite cells
via EdU incorporation following 72h of culturing (Figure 3.4D). Similar to in vivo
results, we found a significant reduction in the proportion of EdU+ myofiber-associated
satellite cells in explant cultures generated from P7:IKKβca mice compared to littermate
Ctrl mice explant cultures (Figure 3.4E).
We further investigated the role of an overstimulation of canonical NF-κB
signaling in satellite cell-derived myogenic cultures, where the cells are not associated
with myofibers. Primary myogenic cultures established from WT mice were transfected
with vector alone (pcDNA3.1) or plasmids expressing WT IKKβ or p65 cDNA [141,
142]. After 72h, we employed an EdU incorporation assay to study cellular proliferation
(Figure 3.4F). Overexpression of IKKβ and p65 resulted in a small, but significant
reduction in EdU incorporation in myogenic cultures (Figure 3.4G) Collectively, these
results suggest that the reduced number of satellite cell in regenerating muscle of
P7:IKKβca mice is due in part to a cell-autonomous defect in proliferation.

3.3.4 Satellite cell-specific overexpression of constitutively active IKKβ promotes cell
death. One of the major roles of the canonical NF-κB signaling is to promote cell
survival. However, sustained activation of NF-κB can also lead to cell death through
apoptosis or necroptosis [127, 128]. Our attempts to perform double immunostaining for
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TUNEL and Pax7 were to no avail, possibly due to the levels of Pax7 being reduced in
satellite cells undergoing apoptosis. Therefore, we once again generated ex vivo myofiber
explants from EDL muscle of P7:IKKβca and Ctrl mice to investigate the effect of supraphysiological activation of the canonical arm of NF-κB signaling on the survival of
myofiber associated satellite cells. Following 72h in culture, the proportion of apoptotic
cells was determined by performing TUNEL labeling. (Figure 3.5A). Interestingly, we
observed an increase in the proportion of myofiber-associated TUNEL+ cells in explant
cultures derived from P7:IKKβca mice compared to Ctrl derived explant cultures (Figure
3.5B).
We next investigated the effect of hyperactivated NF-κB signaling on the survival
of myofiber-free myogenic cultures. WT primary myoblasts were transfected with vector
alone or plasmids expressing WT IKKβ or p65 cDNA for 72h. LDH is a stable enzyme
that is released upon cell death and accumulates in the culture supernatant [147].
Surprisingly, we found no significant changes in the relative levels of LDH in culture
supernatants following IKKβ or p65 overexpression (Figure 3.5C).

3.3.5 Overexpression of IKKβ in satellite cells causes a precocious differentiation of
satellite cells without affecting their self-renewal. It has become increasingly clear that
Pax7 determines the fate of satellite cells in conjunction with different factors, such as
MyoD. Indeed, the expression patterns of Pax7 and MyoD signify the myogenic state of
satellite cells as quiescent (Pax7+/MyoD-), activated (Pax7+/MyoD+), or differentiated
(Pax7-/MyoD+). We next investigated whether the overexpression of IKKβ has any role
in the regulation the myogenic status of satellite cells. To model the satellite cell
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dynamics associated with regenerative myogenesis, we generated ex vivo suspension
cultures of EDL myofibers from P7:IKKβca and Ctrl mice. The ex vivo suspension
cultures were analyzed after 0h and 72h of culturing by staining with Pax7 and MyoD
(Figure 3.6A, 3.6B). We found no significant difference in the number of myofiberassociated satellite cells in cultures prepared from P7:IKKβca and Ctrl mice at 0h
(Figure 3.6C). In both groups, we found a negligible number of MyoD+ expressing
satellite cells at 0h, however, no significant differences were detected between Ctrl and
P7:IKKβca-derived explants (Figure 3.6D).
Satellite cells associated with the myofiber explants formed clusters by 72h of
culturing. There was no significant difference in the average number of clusters per
myofiber (data not shown), nor in the average number of cells per cluster in P7:IKKβca
cultures compared to Ctrl cultures (Figure 3.6E). Furthermore, our analysis showed that
the proportion of self-renewing satellite cells (i.e. Pax7+/MyoD-) was also not
significantly different between control and P7:IKKβca explant cultures (Figure 3.6F).
Interestingly, the proportion of Pax7+/MyoD+ cells was significantly decreased, while
cells that are Pax7-/MyoD+ were significantly increased in cultures derived from
P7:IKKβca mice compared to those derived from Ctrl mice (Figure 3.6G, 3.6H). These
results suggest that supra-physiological activation of IKKβ causes precocious
differentiation of activated satellite cells
We further investigated the role of IKKβ-mediated canonical NF-κB signaling in
the regulation of myogenic fate of satellite cells in a myofiber-free environment. We first
established satellite cell-derived primary myogenic cultures from hind limb muscles of
WT mice. Myogenic cultures taken from early passages were transfected with empty
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vector or plasmids containing IKKβ or p65 cDNA. Following 72h under growth
conditions, the cultures were fixed and then double immunostained for Pax7 and MyoD.
Nuclei were counterstained with DAPI (Figure 3.7A). Consistent with published reports,
we found that the majority of cells were Pax7+/MyoD+, whereas a small proportion was
Pax7+/MyoD- (Figure 3.7B). There was a significant reduction in the proportion of
proliferating cells (Pax7+/MyoD+), while a significant increase was observed in the
proportion of differentiated (Pax7-/MyoD+) cells following the IKKβ or p65
overexpression (Figure 3.7C, 3.7D) consistent with the notion that hyperactivation of
canonical NF-κB signaling in satellite cells compromises their myogenic potential.

3.4 Discussion. Satellite cells normally exist in a quiescent state [123], but are rapidly
activated following injury to skeletal muscle [35]. Similar to other adult stem cells,
satellite cells are capable of maintaining a reserve pool of undifferentiated cells through
self-renewal [17, 33, 35]. A reduction in the satellite cell pool has been linked to an
impairment in the regeneration of skeletal muscle, such as observed in certain genetic
muscle disorders and age-related muscle loss [148-150]. NF-κB plays a major role in the
regulation of cell fate, survival, and differentiation of various cell types [127, 151]. Under
chronic disease states, activation of the canonical NF-κB in skeletal muscle has been
associated with a prolonged inflammatory response contributing to exacerbated
myopathy [127, 128].
In Chapter 2, we showed that physiological levels of canonical NF-κB signaling
in satellite cells promote skeletal muscle regeneration following injury. Here we
demonstrate that the hyperactivation of canonical NF-κB signaling in satellite cells also
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impairs their function during regenerative myogenesis (Figure 3.2, 3.3). These results are
consistent with a recently published report demonstrating that the overexpression of a
constitutively active mutant of IKKβ in satellite cells diminishes muscle repair after
cryoinjury [132]. Indeed, we have previously reported that the overexpression of a
constitutively active mutant of IKKβ induces oxidative stress and reduces survival of
cultured satellite cells [147]. Moreover, sustained activation of the canonical arm of NFκB signaling can also reduce skeletal muscle regeneration by preventing the
differentiation of satellite cells into the myogenic lineage, similar to that reported during
cancer cachexia [116]. Moreover, in the settings of degenerative muscle disorders, the
activation of the canonical arm of NF-κB signaling within satellite cells may also reduce
their myogenic potential. Indeed, partial inhibition of NF-κB has been found to improve
the engraftment of muscle-derived stem cells in dystrophic muscle of Mdx mice [58,
157]. It is notable that while we observed a deficit in muscle regeneration at early time
points (i.e. day 5), skeletal muscle of P7:IKKβca mice eventually regenerate, such that
there is no major difference in muscle structure at day 14 post-injury, suggesting that the
impairment in satellite cell function brought about by the hyperactivation of the canonical
NF-κB pathway is neutralized by the modulatory activity of other factors/pathways that
govern satellite cell function during muscle regeneration.
Skeletal muscle regeneration is a multi-faceted process that is regulated by
numerous signals released from both myogenic and non-myogenic cells that infiltrate the
muscle microenvironment following injury [122, 123]. In response to stimulating cues,
satellite cells undergo transcriptional and translational reprogramming, which in turn
signals for their exit from quiescence into a metabolically activate state, that is conducive
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to their survival [124, 153-155]. Canonical NF-κB signaling is known to induce
proliferation and survival through augmenting the expression of a vast array of cell cycle
and cell growth regulatory molecules [127, 129]. Prior reports have shown that canonical
NF-κB signaling promotes the proliferation of myogenic cells through an up-regulation
of cyclin D1 [156]. Surprisingly, our results demonstrate that the constitutive activation
of IKKβ in satellite cells results in blunted proliferation (Figure 3.4) and survival
(Figure 3.5) of myofiber associated satellite cells.
Cellular proliferation was also reduced upon overexpression of WT IKKβ and p65
in cultured primary myoblasts, although to a modest extent (Figure 3.5). By contrast, we
did not observe any statistical significant differences in cellular survival under similar
settings as evidenced by LDH activity (Figure 3.5). These results, while seemingly
conflicting with our ex vivo experiments where we observed a significant increase in
TUNEL labeled satellite cells of P7:IKKβca myofiber explants, may be due to the
differences in methodology used to detect cell death. There is also the fact that in our in
vivo model of IKKβ overexpression, a constitutively active mutant of IKKβ was
employed, which happens to be resistant to upstream regulation and therefore guarantees
hyperactivation of the NF-κB pathway. On the other hand, WT forms of both IKKβ and
p65 were utilized for the in vitro experiments, where their overexpression might not yield
a sustained activation of the pathway, as is the case in the constitutively active mutant of
IKKβ. Indeed, we have previously reported that the overexpression of IKKβca in vitro
resulted in increased cell death and oxidative stress in primary myogenic cultures [65].
Proper muscle regeneration requires the generation of a sufficient number of
activated satellite cells prior to their fusion to facilitate muscle repair. If the pool of
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activated satellite cells does not meet the regeneration demands due to a defect in
survival, activation, proliferation, or due to premature differentiation, restoration of
muscle homeostasis is compromised. Consistent with this notion, our results demonstrate
that forced activation of canonical NF-κB signaling in satellite cells blunts muscle repair,
in part due to defective cellular proliferation and precocious differentiation (Figure 3.6
and 3.7). On the contrary, previous reports have demonstrated that constitutive activation
of canonical NF-κB signaling in mature skeletal muscle results in an inhibition of
myogenic differentiation [129, 133]. The seemingly discrepant data between these studies
and ours indicates that aberrations in NF-κB signaling have differential roles in the stem
cell population and mature tissue. Indeed, even within the same cell type, we have
reported that different alterations in the canonical NF-κB signaling pathway impacts
different facets of the myogenic process.
In summary, our study provides initial evidence that the conditional activation of
the canonical NF-κB signaling compromises the pool of activated satellite cells and
impairs muscle regeneration. In conjunction with our knockout data, we conclude that
strict monitoring of NF-κB activity in satellite cells is important for the completion of
regenerative myogenesis in adult skeletal muscle. Exhaustion in the satellite cell pool is
observed in many skeletal muscle disorders and pathological conditions [162]. It remains
to be determined whether a satellite cell autonomous defect in canonical NF-κB activity
is associated with such myopathies. Further studies into the differential role of the
canonical arm of NF-κB signaling may pave the road for new therapies for skeletal
muscle pathologies.
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FIGURE 3.1
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FIGURE 3.1 Generation of satellite cell-specific inducible IKKβca overexpressing
transgenic mice. (A) Schematic representation of the breeding strategy used for the
generation of satellite cell-specific IKKβca mice (i.e. P7:IKKβca). (B) Schematic
representation of treatment protocol for tamoxifen-induced Cre recombination and time
points for BaCl2-mediated injury in TA muscle and subsequent muscle collection of
P7:IKKβca and Ctrl mice. (C) Representative photomicrographs of 5d-injured transverse
TA muscle sections of Ctrl and P7:IKKβca mice after immunostaining for Pax7 and
IKKβ. Nuclei were identified by staining with DAPI. Arrow points to nucleus of Pax7+
cell. Scale bar, 10 µm. dpi, days post injury.
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FIGURE 3.2
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FIGURE 3.2 Satellite cell-specific overexpression of IKKβca delays muscle
regeneration in adult mice. (A) Representative photomicrographs of H&E-stained
sections illustrating regeneration defect in injured TA muscle of P7:IKKβca compared
with littermate Ctrl mice at indicated time points after BaCl2 injection. Scale bars: 20 µm.
Quantification of (B) average CSA and (C) minimal Feret’s diameter under naïve
conditions. N=6. Quantification of (D) average myofiber CSA, (E) average minimal
Feret’s diameter, and (F) percentage of myofibers containing two or more centrally
located nuclei per field at day 5 post-injury. N=6. Quantification of (G) average myofiber
CSA, and (H) minimal Feret’s diameter at day 14 post-injury. N=6. #P<0.05, ##P<0.01,
###

P<0.001, values significantly different from corresponding TA muscle of Ctrl mice by

unpaired two-tailed t-test. P7:IKKβca 5 dpi experiment was performed and data was
collected in conjunction with P7:TAK1-KO and P7:TAK1-KO;IKKβca mice. Select data
presented here is also shown in Figure 4.2.
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FIGURE 3.3
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FIGURE 3.3 Overexpression of IKKβca in satellite cells impedes the formation of
new myofibers and reduces the number of satellite cells. (A) Representative
photomicrographs of 5d-injured transverse TA muscle section of Ctrl and P7:IKKβca
mice after immunostaining for eMyHC and Laminin. Nuclei were identified by staining
with DAPI. Scale bar, 20 µm. Quantification of (B) percentage of eMyHC+ myofibers per
Laminin+ myofiber, (C) average CSA of eMyHC+ myofiber, and (D) average minimal
Feret’s diameter of eMyHC+ myofiber in 5d-injured TA muscle of P7:IKKβca and Ctrl
mice. (E) Representative photomicrograph of 5d-injured transverse TA muscle section of
Ctrl and P7:IKKβca mice after immunostaining for Pax7 and Laminin. Nuclei were
identified by staining with DAPI. Arrowhead points to Pax7+ cells. Scale bar, 20 µm. (F)
Quantification of number of Pax7+ cells per Laminin+ myofiber. N=6. (G) Relative
mRNA levels of Pax7 in 5d-injured TA muscle of P7:IKKβca and Ctrl mice. (H)
Relative mRNA levels of various proinflammatory cytokines in 5d-injured TA muscle of
P7:IKKβca and Ctrl mice. #P<0.05, ##P<0.01, ###P<0.001 values significantly different
from corresponding TA muscle of Ctrl mice by unpaired two-tailed t-test.
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FIGURE 3.4
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FIGURE 3.4 Overexpression of IKKβca in satellite cells diminishes satellite cell
proliferation. TA muscle of P7:IKKβca and Ctrl mice was injured by intramuscular
injection of 100 µl of 1.2% BaCl2 solution. After 2 days, the mice were given an
intraperitoneal injection of EdU and 12 days later TA muscles were collected and muscle
sections prepared were stained to detect EdU, Laminin, and nuclei. (A) Representative
photomicrograph of 14d-injured TA muscle section of Ctrl and P7:IKKβca mice after
processing for EdU deletion and anti-Laminin staining. Nuclei were identified by staining
with DAPI. Arrowhead points to interstitial EdU+ nuclei. Arrow points to
intramyofibrillar EdU+ nuclei. Scale bar, 20 µm. Quantification of (B) interstitial EdU+
and (C) intramyofibrillar EdU+ nuclei per Laminin+ myofiber in TA muscle of Ctrl and
P7:IKKβca mice. N=4. Single myofibers cultures were established from EDL muscle of
Ctrl and P7:IKKβca mice and cultured for 72h. The cells were pulse labeled with EdU for
last 90 minutes. The myofiber cultures were then stained for EdU. Nuclei were labeled by
incubation in DAPI. (D) Representative merged images of EdU and DAPI staining are
presented here. Scale bar, 10 µm. (E) Quantification of percentage of EdU+ cells per
cluster. Cluster was defined as ≥4 cells. N=10-11 fibers per group. (F) Cultured primary
myogenic cultures were transfected with vector alone or plasmid vector overexpressing
(OE) IKKβ or p65 cDNA. After 72h, the cells were pulse labelled with EdU for 90 min.
Representative merged images of cultures after processing for EdU detection and staining
with DAPI. Scale bar, 10 µm. (G) Quantification of percent EdU+ cells. N=4. #P<0.05,
##

P<0.01 values significantly different from TA muscle or myofiber suspension culture of

Ctrl mice by unpaired two-tailed t-test. ^P<0.05, values significantly different from
pcDNA3.1 control plasmid by unpaired two-tailed t-test.
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FIGURE 3.5

94

FIGURE 3.5 Satellite cell-specific overexpression of IKKβca causes an increase in
apoptotic cell death. (A) Single myofiber suspension cultures were established from
EDL muscle of 6-week old P7:IKKβca and Ctrl mice, and cultured for 72h then
processed for detection of TUNEL+ nuclei. Nuclei were identified by staining with DAPI.
Scale bar, 10 µm. (B) Quantification of percentage of TUNEL+ cells per cluster. Cluster
was defined as ≥4 cells. N=10-11 myofibers per group. (C) Quantification of relative
LDH activity (fold change) following IKKβ and p65 overexpression (OE) plasmid
transfection. #P<0.05, values significantly different from corresponding myofiber
suspension culture of Ctrl mice by unpaired two-tailed t-test. ^P<0.05, values
significantly different from pcDNA3.1 control plasmid by unpaired two-tailed t-test.
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FIGURE 3.6
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FIGURE 3.6 Satellite cell-specific overexpression of IKKβca results in the
precocious differentiation of satellite cells without affecting their self-renewal. Single
myofiber suspension cultures were established from EDL muscle of 6-week old
P7:IKKβca and Ctrl mice, and cultured for 0 or 72 hours. The cultures were fixed and
immunostained for Pax7 and MyoD. Representative individual and merged images of (A)
freshly isolated and (B) 72h cultured myofibers from Ctrl and P7:IKKβca mice stained
with Pax7, MyoD, and DAPI. Quantification of frequency of (C) Pax7+ cells per
myofiber, and (D) MyoD+ cells per myofiber in Ctrl and P7:IKKβca a 0h. Quantification
of (E) average number of cells per cluster, (F) percentage of Pax7+/MyoD- cells per
cluster, (G) percentage of Pax7+/MyoD+ cells per cluster, and (H) percentage of Pax7/MyoD+ cells per cluster in Ctrl and P7:IKKβca at 72h of culturing. Cluster was defined
as ≥4 cells. N=10-11 myofibers per group. #P<0.05, ##P<0.01 values significantly
different from corresponding myofiber suspension culture of Ctrl mice by unpaired twotailed t-test.

98

FIGURE 3.7
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FIGURE 3.7 Overexpression of IKKβ or p65 result in a precocious differentiation of
cultured satellite cells. Primary myogenic cultures establish from hind limb muscle of
WT mice were transfected with vector alone (i.e. pcDNA3.1) or with wild type IKKβ or
p65 cDNA for 72h. (A) Representative photomicrographs of the cultures after
immunostaining for Pax7 and MyoD. Nuclei were identified by staining with DAPI.
Quantification of (B) percentage of Pax7+/MyoD- cells, (C) percentage of Pax7+/MyoD+
cells, and (D) percentage of Pax7-/MyoD+ cells in control, IKKβ, or p65-overexpressing
(OE) cultures. N=3. ^P<0.05, values significantly different from pcDNA3.1 control
plasmid by unpaired two-tailed t-test.
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CHAPTER 4

CONSTITUTIVE ACTIVATION OF IKKβ FAILS TO RESTORE THE
REGENERATION DEFICIT CAUSED BY THE SATELLITE CELL-SPECIFIC
ABLATION OF TAK1

4.1 Introduction. A temporal activation of various signaling pathways has been shown to
regulate distinct stages of satellite cell-mediated myogenesis. For example, while
activation of Notch signaling promotes satellite cell self-renewal, its continued
stimulation inhibits differentiation through repressing the expression of MyoD [35].
Moreover, the Wnt7a/Fzd7 planar-cell-polarity pathway drives the symmetric expansion
of satellite stem cells during their proliferative phase [68]. On the other hand, the
canonical Wnt3a/β-catenin pathway has been shown to be involved in regulating satellite
cell differentiation and subsequent fusion [68]. It has also been shown that MAPK
signaling pathways regulate myogenesis in a context dependent manner [80].
Angiotensin-1/Tie-2 mediated signaling increases the number of quiescent satellite cells
through activation of the ERK1/2 signaling pathway [67]. By contrast, activation of p38
MAPK in satellite cells inhibits self-renewal and promotes differentiation [69].
Consistently, work from our lab has shown that the adaptor protein TRAF6 is required
for maintaining the quiescent state of un-stimulated satellite cells and promoting their
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proliferation following activation through its downstream targets ERK1/2 and JNK1/2,
and through the suppression of p38 MAPK [117]. Moreover, the canonical nuclear factorkappa B (NF-κB) pathway, activated through inhibitor of kappa B kinase-β (IKKβ),
promotes the expansion of satellite cells and blocks their terminal differentiation in the
context of cancer cachexia [108]. Work from our lab has also shown that sustained
activation of canonical NF-κB signaling in response to TWEAK (a proinflammatory
cytokine) treatment diminishes the number Pax7+ satellite cells in vitro and ex vivo [140].
The findings in Chapter 2 and 3 of this thesis demonstrate that physiological levels of
IKKβ are important for maintaining the survival and proliferation of activated satellite
cells in injured muscle, and preventing their precocious differentiation. While the role of
canonical NF-κB signaling in satellite cell homeostasis and myogenesis is becoming
increasingly evident, the upstream signaling events that dictate its activation status
remain less understood.
Transforming growth factor-β-activated kinase 1 (TAK1) is an important
signaling protein of the MEK Kinase family that activates various signaling cascades in
response to a variety of stimuli [103]. TAK1-mediated signaling is initiated through its
interaction with accessory protein TAB1, which constitutively binds and activates TAK1
[104]. The TAK1 complex is activated in response to proinflammatory stimuli via K63linked polyubiquitination driven by the E2 ligase, UBC12/UEV1A, and the RING finger
E3 ligases TRAF2 or TRAF6 [105, 106]. K63-linked polyubiquitin chains are then bound
by TAB2 and TAB3, which have a strong affinity to activate TAK1 through inducing
conformational changes in TAK1, leading to its autophosphorylation at Thr187, which
initiates the activation of downstream signaling targets, such as NF-κB [106]. Here,
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activated TAK1 phosphorylates IKKβ on its activation loop, leading to its activation and
a subsequent phosphorylation of IκBα [100, 101]. IκBα is then polyubiquitinated through
Lys48-linked polyubiquitin chains and degraded by the proteasome [101]. Free from IκB,
canonical NF-κB component RelA/p50 translocates to the nucleus to induce transcription
of target genes [101].
We have previously reported that the targeted deletion of TAK1 in satellite cells
(TAK1scko) lead to severe deficits in muscle regeneration following BaCl2-mediated
injury [65]. TAK1 was found to be essential for satellite cell proliferation and its
inactivation resulted in their precocious differentiation into the myogenic lineage [65].
TAK1-deficient satellite cells exhibit an increase in oxidative stress and necroptosismediated cell death resulting in the depletion of the satellite cell pool [65]. Our findings
further revealed that TAK1 regulates satellite cell homeostasis, in part, by activating JNK
and canonical NF-κB signaling pathways [65]. Forced expression of constitutively active
mutants of JNK and IKKβ improved the proportion of Pax7+ satellite cells, blunted
oxidative stress, and promoted the survival of TAK1-deficient myogenic cells [65].
However, it remains to be determined whether similar molecular mechanisms are
responsible for the poor skeletal muscle regeneration phenotype observed in TAK1scko
mice following muscle injury [65].
Given the proximate hierarchical positioning of TAK1 and the pathway at the
center of this thesis; i.e. the canonical NF-κB signaling pathway, we next sought to
investigate weather forced activation of canonical NF-κB signaling in TAK1-deficient
satellite cells would restore proper muscle regeneration in vivo. Through the generation
of inducible satellite cell-specific TAK1 knockout, IKKβ constitutively active mice, we
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demonstrate that constitutive activation of IKKβ in TAK1-deficient satellite cells does
not rescue the regeneration defects observed in P7:TAK1-KO (previously TAKscko) mice
following BaCl2 mediated injury.

4.2 Materials and methods.
Animals. Satellite cell-specific inducible TAK1-knockout/IKKβ-overexpression mice
+/-

(i.e. TAK1flox/flox;R26-Stopflox/flox IKK2ca;Pax7Cre ) were generating by crossing R26Stop floxed IKK2ca mice with a previously generated satellite cell-specific inducible
TAK1-knockout mouse (i.e. P7:TAK1-KO). All mice were in the C57BL/6J background
and their genotype was determined by PCR from tail DNA. For Cre-mediated inducible
concurrent knockout of TAK1 and overexpression of IKKβ, TAK1 knockout alone, and
overexpression of IKKβ alone, 12-week old mice were injected i.p. with Tamoxifen (10
mg per Kg body weight) for five consecutive days. Control mice were injected with corn
oil only. The IACUC and IBC of the University of Louisville approved all experimental
protocols with mice in advance.

Skeletal muscle injury. One week after the first injection of tamoxifen, 100µL of 1.2%
BaCl2 (Sigma Chemical Co.) in saline was injected into the TA muscle of mice to induce
necrotic muscle injury. At various time points, TA muscle was collected from euthanized
mice for biochemical and histological studies.

Histology and morphometric analysis. For skeletal muscle morphology and
regeneration assessment, 10 µm-thick transverse sections of the TA were stained with
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Hematoxylin and Eosin. For quantitative analysis, CSA, minimum Feret’s diameter, and
multinucleation were analyzed in H&E stained TA muscle sections. H&E slides were
mounted using DPX Mountant For Histology Slide mounting medium (Sigma Chemical
Co.) and visualized at room temperature on a Nikon Eclipse TE 2000-U Microscope
(Nikon), a digital camera (Nikon Digital Sight DS-Fi1), and Nikon NIS Elements BR
3.00 software (Nikon). Exposure time was kept at 80ms and contrast levels were not
altered.

Statistical analyses. For the sake of transparency, results were expressed as box-andwhisker plots with the box comprised of the 1st, 2nd, and 3rd quartiles, and the lower and
upper whiskers corresponding to the minimum and maximum values, respectively, to
display the entire range of data. For experiments involving more than two groups, one
way analysis of variance (ANOVA) was performed followed by Tukey’s Honest
Significant Difference (HSD) post hoc analysis to determine significant differences
between groups.

4.3 Results
4.3.1 Satellite cell-specific deletion of IKKβ fails to rescue the regeneration defects
caused by the specific deletion of TAK1. Stemming from our previous findings where
forced expression of a constitutively active mutant of IKKβ rescued myogenic function in
TAK1-deficient primary myoblasts, we aimed to employ a similar genetic approach in
vivo. Accordingly, we crossed TAK1flox/flox/Pax7Cre+/- (i.e. P7:TAK1-KO, previously
TAKscko) with R26-Stopflox/flox IKK2ca mice utilized in our investigations in Chapter 3 to
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+/-

generate inducible TAK1flox/flox;R26-Stopflox/flox IKK2ca;Pax7Cre

mice , henceforth

referred to as P7:TAK1-KO;IKKβca mice (Figure 4.1A).

4.3.2 Forced expression of IKKβ in TAK1-deficient satellite cells yields no
improvement in regeneration in vivo. Twelve-week-old P7:TAK1-KO only, P7:TAK1KO;IKKβca, and P7:IKKβca only mice were injected with tamoxifen to induce Crerecombination, or treated with corn oil alone as a vehicle control (TAK1 control,
TAK1;IKKβ control, and IKKβ control, respectively) (Figure 4.1B). Three days later,
TA muscle of the aforementioned 6 groups were given intramuscular injections of 100µl
of 1.2% BaCl2 to induce necrotic muscle injury and regeneration was analyzed at day 5
post-injury. We analyzed the TA muscles through performing H&E staining on
transverse sections (Figure 4.2A) and subsequent quantification of: myofiber CSA
(Figure 4.2B), minimum Feret’s diameter (Figure 4.2C), and percentage of centrally
multinucleated myofibers (Figure 4.2D). The regeneration phenotype observed in the
P7:TAK1-KO;IKKβca mice resulted in a regeneration pattern that was intermediate
between the P7:TAK1-KO mice and the P7:IKKβca, with the P7:TAK1-KO mice
showing the largest CSA, minimum Feret’s diameter, and percentage of centrally
multinucleated fibers. A similar trend was seen between the controls, where the TAK1
control mice showed the largest CSA, minimum Feret’s diameter, and percentage of
centrally multinucleated fibers, the IKKβ control showing the smallest values for the
aforementioned parameters, and the TAK1;IKKβ control having values intermediate
between the other two controls. Significant difference between groups was determined by
one-way ANOVA followed by Tukey’s HSD post hoc analysis to determine which
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groups were significantly different from each other. A summary of these findings is
found in Figure 4.2B-D. Collectively, these findings demonstrate that constitutive
activation of IKKβ in TAK1-deficient satellite cells does not rescue the muscle
regeneration defect brought about by TAK1 deletion.

4.4 Discussion. Satellite cells are muscle stem cells that facilitate muscle repair. Like
other adult stem cell, satellite cells retain the capacity to self-renew, through which, a
constant pool of healthy cells is maintained. While normally residing in a quiescent state,
satellite cells are activated in response to injury or rigorous exercise, where they undergo
several rounds of cell division to produce fusion competent myoblasts to support muscle
growth and repair. A reduction in the pool of functional satellite cells compromises
muscle regeneration and eventually leads to loss of muscle mass, similar to as observed
in various genetic muscle disorders.
We have previously reported that the deletion of TAK1 in satellite cells impedes
muscle regeneration following injury due to satellite cell dysfunction. Our findings
revealed that TAK1 is required for sustaining satellite cell myogenicity through
maintaining the expression of Pax7 and supporting satellite cell survival. Overexpression
of constitutively active mutant of IKKβ rescued the expression of Pax7 and abrogated
cell death of TAK1-deficient myogenic cultures. In the current study, we aimed to
investigate whether a similar approach would yield similar results in vivo and would
manifest in efficient muscle regeneration of P7:TAK1-KO muscle. However, unlike our
in vitro results, conditional overexpression of constitutively active IKKβ (i.e. IKKβca) in
TAK1-knockout satellite cells did not improve muscle regeneration. Defects observed in
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muscle repair were fairly comparable following injury in skeletal muscle of P7:TAK1KO;IKKβca and P7:TAK1-KO mice. While these results may indicate that TAK1
function in satellite cells is independent of NF-κB in vivo, further investigations are
warranted. It remains to be seen whether the lack of improvement in regenerating muscle
of P7:TAK1-KO;IKKβca is merely a result of the supra-physiological activation of the
canonical NF-κB pathway, and not necessarily an absence of hierarchical signaling
transduction between TAK1 and IKKβ in satellite cells of regenerating muscle. Indeed
our results from Chapter 3 and accordingly from the current chapter revealed that a
heightened activation of the canonical NF-κB pathway via overexpression of IKKβca in
satellite cells impedes muscle regeneration in vivo. Therefore, it is in the realm of
possibility that overexpression of a WT form of IKKβ or the introduction of more
physiologically relevant levels of IKKβ in TAK1-deficient satellite cells would indeed
yield an improvement in muscle regeneration. While such investigations would lend
important insight into the possible mechanisms through which TAK1 functions in
satellite cells in vivo, it is beyond the scope of this thesis, however, will be the subject of
future research in our lab.
Altogether, our previous findings complimented with the results of this chapter
indicate that the implementation of similar strategies in vitro and in vivo does not
necessarily yield comparable outcomes. While a forcible expression of IKKβca restored
cell function in TAK1-deficient myogenic cultures, no such improvement was observed
in satellite cell-mediated muscle regeneration in P7:TAK1-KO muscle. Forthcoming
investigations will elucidate the ambiguity of the aforementioned findings.
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FIGURE 4.1
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FIGURE 4.1 Generation of satellite cell-specific IKKβca overexpressing and Tak1knockout mice. (A) Schematic representation of the breeding strategy used for the
generation of concurrent satellite cell-specific TAK1-knockout/IKKβ-overexpression
mice. (B) Treatment protocol for tamoxifen-induced Cre recombination and subsequent
muscle collection time points in P7:TAK1-KO mice, littermate TAK1 Control,
P7:TAK1-KO;IKKβ-CA mice, littermate TAK1;IKKβ Control mice, P7:IKKβca mice,
and IKKβ Control mice.
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FIGURE 4.2
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FIGURE 4.2 Overexpression of IKKβ in satellite cells fails to rescue muscle
regeneration deficit in TAK1scko mice. (A) Representative photomicrographs of H&Estained sections of 5-days injured TA muscle of 12-week old: P7:TAK1-KO mice,
littermate TAK1 Ctrl, P7:TAK1-KO;IKKβca mice, littermate TAK1;IKKβ Ctrl mice,
P7:IKKβca mice, and IKKβ Ctrl mice following BaCl2-mediated necrotic injury. N=5, 5,
4, 4, 6, 6, respectively. Scale bar, 20 µm. Quantification of (B) average myofiber CSA,
(C) minimal Feret’s diameter, and (D) the percentage of myofibers containing two or
more centrally located nuclei per field at day 5 post-injury. ^P values significantly
different from corresponding TA muscle of TAK1 Ctrl mice by Tukey’s HSD post hoc
analysis. $P values significantly different from corresponding TA muscle of TAK1;IKKβ
Ctrl mice by Tukey’s HSD post hoc analysis. #P values significantly different from
corresponding TA muscle of IKKβ Ctrl mice by Tukey’s HSD post hoc analysis. %P
values significantly different from corresponding TA muscle of P7:TAK1-KO mice by
Tukey’s HSD post hoc analysis. &P values significantly different from corresponding TA
muscle of P7:TAK1-KO;IKKβca mice by Tukey’s HSD post hoc analysis. P7:IKKβca 5
dpi data experiment was performed and was collected in conjunction with P7:TAK1-KO
and P7:TAK1-KO;IKKβca mice. Select data presented here is also shown in Figure 3.2.
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CHAPTER 5

CONCLUSIONS AND FUTURE WORK

This chapter is a summary of the work presented in this dissertation. It discusses the
implications in satellite cell homeostasis and function with respect to canonical NF-κB
signaling. Additionally, it highlights the significance of the findings presented in this
dissertation and acknowledges experimental limitations applicable to future research.

5.1 Review of Dissertation. Skeletal muscle is a highly plastic tissue that is capable of
repairing itself following physiological insult. The capability of skeletal muscle to
regenerate itself following injury is primarily attributed to its satellite stem cell
population. Signaling within (un)-injured muscle fibers, as well as in immunological cells
that populate the injured skeletal muscle microenvironment, also contribute to various
facets of regenerative myogenesis. Through examination of the role of IKKβ, a central
kinase of canonical NF-κB signaling, the findings of this dissertation underscore the
complex nature surrounding molecular events that occur during homeostasis of the
satellite stem cell and its functional role during regenerative myogenesis. Our results
indicate that IKKβ-mediated canonical NF-κB signaling facilitates the repair process
post-injury and maintains the myogenic status of activated satellite cells.
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The findings detailed in Chapter 2 revealed that the ablation of IKKβ in satellite
cells inhibits the process of skeletal muscle regeneration following an acute injury due to
a reduction in satellite cell proliferation and survival. Our results suggest that IKKβ and
p65-mediated canonical NF-κB signaling promotes the survival, proliferation, and selfrenewal of activated satellite cells. Indeed, it appears that satellite cells signal the
canonical NF-κB pathway after skeletal muscle injury to increase the satellite stem cell
population, and thereby facilitate in the proper regeneration of skeletal muscle. While
various inflammatory molecules are expressed following injury, our results suggest that
satellite cells do not modulate the expression of these inflammatory cytokines. In various
experiments, uninjured skeletal muscle and associated quiescent satellite cells displayed
no noticeable phenotype following the satellite cell-specific ablation of IKKβ, suggesting
that the canonical NF-κB pathway has a limited impact, if any, on the regulation of
quiescent satellite cells.
As discussed in Chapter 3, we explored the effect of supra-physiological
activation of the canonical NF-κB signaling pathway in satellite cells. Since depletion of
IKKβ was deleterious for satellite cell function during regenerative myogenesis, we
questioned whether over-stimulation of the canonical NF-κB pathway via IKKβca
overexpression would yield beneficial outcomes. However, this did not turn out to be the
case. Similar to as observed with IKKβ deletion, forced expression of IKKβ in satellite
cells also compromised satellite cell function and impeded muscle regeneration. Indeed
these results are consistent with published reports where various myopathic disorders
were associated with heightened activation of canonical NF-κB pathway. Furthermore,
our data suggest that differential aberrations in canonical NF-κB signaling alter different
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facets of regenerative myogenesis. While both knockout and overexpression of IKKβ in
satellite cells resulted in their precocious differentiation and a reduction in their
proliferation and survival, only in the context of the satellite cell-specific IKKβ deletion
did we see a reduction in satellite cell self-renewal. It remains to be determined whether
the similar phenotypic outcomes observed from both interventions are result of common
upstream mechanisms or occur in a distinct manner.
The focus of Chapter 4 was to investigate whether overexpression of the
canonical NF-κB pathway via a constitutively active IKKβ mutant would ameliorate the
effects of TAK1 deficiency in satellite cells in an in vivo setting. Previous work from our
lab revealed a deleterious regeneration phenotype following the specific ablation of
TAK1 in satellite cells. Overexpression of a constitutively active mutant form of IKKβ in
vitro rescued myogenic function in TAK1-deficient satellite cell-derived myogenic
cultures as evidenced by the restoration of Pax7 expression and an increase in cellular
survival and proliferation. However, no such improvement was observed. Regeneration
deficits were still evident following the conditional overexpression of IKKβca in TAK1
knock out satellite cells (P7:TAK1-KO;IKKβca) in vivo, indicating lack of improvement
in satellite cell function.
Collectively, the results of this dissertation indicate that canonical NF-κB
signaling, mediated by IKKβ, is a versatile modulator of both satellite stem cells and
mature skeletal muscle. From our data and taken in conjunction with the current
literature, it is becoming increasingly evidenced that a single signaling module may carry
distinct functions within various stages of the myogenic lineage. While it has been widely
reported that activation of canonical NF-κB signaling in differentiated muscle is
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associated with virulent outcomes, our findings are suggestive of a supportive role of NFκB in satellite cell function. However, such role is dictated by a precise regulation of NFκB activity, as both under- and over-stimulation of the pathway had an adverse effect on
the myogenic capacity of satellite cells.

5.2 Scientific contribution and future implementation. The data shown in this
dissertation identifies a previously unrecognized role for canonical NF-κB signaling in
satellite cell-mediated regenerative myogenesis. Aberrant activation of canonical NF-κB
signaling has been observed in various pathological conditions such as Duchenne
muscular dystrophy and Rhabdomyosarcoma. Accordingly, therapeutic strategies aimed
at abolishing the activity of NF-κB have been implemented in treating such disorders in
pre-clinical animal models, and have been reported to be advantageous. However, most
studies were focused on evaluating specific disease parameters and were carried out for a
short period of time. Such research approaches may result in an oversight of possible
deleterious outcomes in various parameters or cell types that do not fall under the
evaluation criteria. Furthermore, short-term evaluations may have failed to identify
possible virulent outcomes, such as loss of satellite cell function, which may have
manifested from NF-κB inhibition in the long run. The findings from this dissertation
emphasize a formerly overlooked biological significance for the canonical NF-κB
signaling in activated satellite cells. As such, our findings underscore the importance of
implementing a holistic approach upon evaluating target-based therapies. Therefore, a
global long-term evaluation is required upon targeting NF-κB signaling in a myopathic
disease setting.
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Our findings from Chapters 2 and 3 reveal that over- and under-stimulation of the
canonical NF-κB pathway compromises satellite cell myogenic potential. Furthermore,
our findings from Chapter 4 demonstrated that forced activation of canonical NF-κB
signaling in TAK1-deficient satellite cells did not improve muscle regeneration in
P7:TAK1-KO mice, despite a similar approach yielding beneficial results in vitro. Such
outcomes illustrate the importance of a precise regulation of NF-κB activity within
satellite cells to drive proper myogenic function. Exhaustion in satellite cell function and
number has been observed in many pathological conditions as well as in age-associated
muscle loss. However, the molecular mechanisms that elicit such manifestations remain
unknown. It is conceivable that satellite cells cell-autonomous aberration of NF-κB
signaling drives the loss of myogenic potential within certain disease contexts. Therefore,
reclaiming physiological levels of NF-κB activity within satellite cells may prove to be
beneficial in treating various muscle disorders.

5.3 Limitations of future implementation. This dissertation concludes in identifying
canonical NF-κB signaling, mediated through IKKβ, as a regulator of the myogenic
status of activated satellite cells and a mediator of regeneration of skeletal muscle
following injury. However, the work presented here and taken in conjunction with current
literature suggests that a cell specific approach would preclude any therapeutic strategies.
The ablation of canonical NF-κB signaling in mature skeletal muscle has been shown to
be beneficial for regenerative myogenesis, but the work presented here suggests that it
would be deleterious in the satellite stem cell population. While genetic engineering
techniques do allow for the conditional deletion/overexpression of various molecules in
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laboratory mouse models, such methodology is not currently available/viable within the
realm of translational research. Thus, any pharmacological approaches to inhibiting
canonical NF-κB signaling might have deleterious outcomes in the long term due to the
differential effects on stem cells and mature tissues. To elevate the significance of the
findings contained within this dissertation, a translational approach allowing for cellspecific alterations in mature tissues types that spared the stem cell population would
need to be generated. Lastly, the work in Chapter 4 did not yield a rescue phenotype
following the overexpression of IKKβ in TAK1-deficient satellite cells in vivo, unlike
was observed when a similar approach was employed in vitro. It remains to be seen
whether this is owed to the supra-physiological activation of the canonical NF-κB
pathway, which was shown to impede satellite cell-mediated muscle regeneration, as was
observed in Chapter 3, or if IKKβ is acting independently of TAK1 in satellite cells in
vivo. Along similar lines, in Chapters 3 and 4, the extent to which the canonical NF-κB
pathway was activated was not elucidated. Future work should be performed to determine
what levels of signaling the canonical NF-κB pathway produces a therapeutic effect with
respect to satellite cell homeostasis and regenerative myogenesis.
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APPENDICES
APPENDIX-1
Sequence of the primers used in qRT-PCR assay.

Gene Name

β-actin
IFN-γ
IL-1β
IL-6

Forward Primer (5'-3')

Reverse Primer (5'-3')

CAG GCA TTG CTG ACA GGA TG

TGC TGA TCC ACA TCT GCT GG

GAC AAT CAG GCC ATC AGC AAC
CTC CAT GAG CTT TGT ACA AGG

CGG ATG AGC TCA TTG AAT GCT T
TGC TGA TGT ACC AGT TGG GG

ATG GCA ATT CTG ATT GTA TG
CAG TGT GCC ATC TAC CCA TGC
TTA

TGG CTT TGT CTT TCT TGT TA

Pax7
Myf5 TGA AGG ATG GAC ATG ACG GAC G
Myh3 ACA TCT CTA TGC CAC CTT CGC TAC
Myh4 CGG CAA TGA GTA CGT CAC CAA A
MyoD TGG GAT ATG GAG CTT CTA TCG C
Myogenin CAT CCA GTA CAT TGA GCG CCT A
AGC ACA GAA AGC ATG ATC CG
TNF-α
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GGT GCT TGG TTC AAA TTG AGC C
TTG TGT GCT CCG AAG GCT GCT A
GGG TCT TGG TTT CGT TGG GTA T
TCA AAG CCA GCG ATG TCC AA
GGT GAG TCG AAA CAC GGA TCA T
GAG CAA ATG ATC TCC TGG GTT G
GCC ACA AGC AGG AAT GAG AA

APPENDIX-2
List of abbreviations.

AAV – Adeno-associated Virus
ATP – Adenosine Triphosphate
AV – Annexin V
BaCl2 – Barium Chloride
bFGF – Basic Fibroblast Growth Factor
BMP – Bone Morphogenetic Proteins
BSA – Bovine Serum Albumin
ca – Constitutively Active
cDNA – Complimentary Deoxyribonucleic Acid
c-Met – Tyrosine-Protein Kinase Met
Cre – Cyclase Recombinase
CSA – Cross-Sectional Area
DAPI – 4',6-diamidino-2-phenylindole
DAMP – Damage-associated Molecular Pattern
DMEM – Dulbecco Modified Eagle Medium
DMSO – Dimethyl Sulfoxide
DNA – Deoxyribonucleic Acid
EDL – Extensor Digitorum Longus
EdU – 5-ethynyl-2′-deoxyuridine
eMyHC – Embryonic Myosin Heavy Chain
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ERK – Extracellular Signal-Regulated Kinase
FBS – Fetal Bovine Serum
FGF – Fibroblast Growth Factor
Fig. – Figure
GM – Growth Medium
H&E – Hematoxylin and Eosin
HGF – Hepatocyte Growth Factor
IACUC – Institutional Animal Care and Use Committee
IBC – Institutional Biosafety Committee
ICC – Immunocytochemistry
IFN – Interferon
IGF – Insulin-like Growth Factor
IHC – Immunohistochemistry
IκB – Inhibitor of κB
IKK – Inhibitor of κB Kinase
IL – Interleukin
i.p. – Intraperitoneal
JAK – Janus Kinase
JNK – c-Jun N-terminal Kinase
KO – Knockout
LBX – Ladybird Homeobox 1
LIF – Leukemia Inhibitory Factor
MAPK – Mitogen Associated Protein Kinase
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MEK – Mitogen Associated Protein Kinase-Extracellular Signal-Regulated Kinase
Mox2 – Mesenchyme Homeobox 2
MRF – Myogenic Regulatory Factor
mTOR – Mechanistic Target of Rapamycin
mRNA – Messenger RNA
MyD88 – Myeloid Differentiation Primary Response 88
Myf – Myogenic Factor
MyHC – Myosin Heavy Chain
MyoD – Myoblast Determination Factor (1)
NF-κB – Nuclear Factor-κB
NICD – Notch Intracellular Domain
PAMP – Pathogen-associated Molecular Pattern
Pax3 – Paired Box Protein 3
Pax7 – Paired Box Protein 7
PBS – Phosphate Buffered Saline
PCR – Polymerase Chain Reaction
PFA – Paraformaldehyde
PI – Propidium Iodide
qRT-PCR – Quantitative Real-Time Polymerase Chain Reaction
RBP-Jκ – Recombining Signal Binding Protein for Immunoglobulin Jκ
RNA – Ribonucleic Acid
STAT – Signal Transducer and Activators of Transcription Protein
TA – Tibialis Anterior
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TAB – TGF-β Activated Kinase (MAP3K7) Binding Protein
TAK1 – Transforming Growth Factor β-Activated Kinase 1
TGF-β – Transforming Growth Factor-β
TIRAP – TIR-Domain Containing Adaptor Protein
TLR – Toll-like Receptor
TNF – Tumor Necrosis Factor
TNFR – Tumor Necrosis Factor Receptor
TRAF6 – TNF Receptor-Associated Factor 6
TRAM – Transduction Associated Membrane Protein
TRIF – TIR-Domain Containing Adaptor-Inducing Interferon- β
TUNEL – Terminal deoxynucleotidyl transferase dUTP Nick-End Labeling
Wnt – Wingless-Related Integration Site
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APPENDIX-3
List of antibodies.

Antibody

Source and Catalog Number

Dilution Analysis

Goat Anti-Rabbit IgG, Alexa

Thermo Fischer Scientific, A-

1:2000

ICC/IHC

Fluor® 488 conjugated (H+L)

11055

F(ab’)2-Goat Anti-Mouse IgG,

Thermo Fischer Scientific, A-

1:2000

ICC/IHC

Alexa Fluor® 594 Cross-

11018

1:2000

ICC/IHC

1:2000

ICC/IHC

Adsorbed (H+L)
Goat Anti-Mouse IgG1, Alexa

Thermo Fischer Scientific, A-

Fluor® 568 conjugated (H+L)

21124

Goat Anti-Mouse IgG2b, Alexa

Thermo Fischer Scientific, A-

Fluor® 488 conjugated (H+L)

21141

Polyclonal rabbit-anti-BAX

Cell Signaling Technology, 2772 1:1000

WB

Polyclonal rabbit-anti-Bcl2

BD Biosciences, 554279

1:1000

WB

Monoclonal rabbit-anti-Cleaved

Cell Signaling Technology, 9664 1:1000

WB

Cell Signaling Technology, 9544 1:1000

WB

Santa Cruz Biotechnology, sc-

1:1000

WB

1:1000

WB

Caspase-3
Polyclonal rabbit-anti-Cleaved
PARP
Polyclonal rabbit-anti-Cyclin A

596
Polyclonal rabbit-anti-Cyclin D1

Santa Cruz Biotechnology, sc717
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Monoclonal mouse-anti-eMyHC

DSHB, F1.652

1:200

IHC

Monoclonal rabbit-anti-phospho-

Cell Signaling Technology, 2859 1:500

WB

Monoclonal rabbit-anti-total IκBα

Cell Signaling Technology, 4812 1:500

WB

Polyclonal rabbit-anti-total IKKβ

Cell Signaling Technology, 2684 1:500

WB

Polyclonal rabbit-anti-Laminin

Sigma, L9393

1:150

IHC

Monoclonal mouse-anti-MyoD

Santa Cruz Biotechnology, sc-

1:200,

ICC,

377460

1:1000

WB

DSHB, pax7

1:100,

WB,

1:5

ICC/IHC

IκBα

Monoclonal mouse-anti-Pax7

Monoclonal rabbit-anti-phospho

Cell Signaling Technology, 3033 1:1000

WB

Monoclonal rabbit-anti-total p65

Cell Signaling Technology, 8242 1:1000

WB

Monoclonal rabbit-anti-alpha-

Cell Signaling Technology, 2125 1:1000

WB

p65

tubulin
ICC – immunocytochemistry; IHC – immunohistochemistry; WB – western blot

140

APPENDIX-4
Camera equipment and settings, exposure time, and contrast modifications
Microscopes:
ICC/IHC: Nikon TiE 3000 Inverted microscope
H&E: Nikon Eclipse TE 2000-U microscope
Cameras:
ICC/IHC: DXM-1200C coded digital camera
H&E: Nikon Digital Sight DS-Fi1
Acquisition Software: NIS Elements
Space Resolution:
ICC/IHC: 2560 x 2160; 0.33 microns per pixel @ 20x objective, 0.65 microns per
pixel @ 10x objective
H&E: 2560 x 1920; 0.24 microns per pixel @ 20x objective
Imaging Medium:
ICC/IHC: Aqua-Poly (Polysciences, Inc.)
H&E: DPX Mountant For Histology Slide (Sigma Chemical Co.)
Exposure and Contrast:
H&E: 80ms exposure time; no contrast editing
ICC/IHC

Settings

TRITC (Red)

Image
Pax7/IKKB
IHC

Objective

Exposure

Low

High

Exposure

Low

High

Exposure

Low

High

20x

2sec

7710

42405

1.5sec

3855

53970

100ms

3855

53970

20x

300ms

3855

42405

2sec

3855

23130

80ms

3855

53970

20x

2sec

3855

42505

300ms

3855

23130

80ms

3855

53970

20x

1sec

7710

42405

200ms

3855

50115

60ms

7710

57825

20x

2sec

7710

42405

400ms

3855

42405

80ms

3855

42405

20x

2sec

7710

42405

1sec

3855

42405

60ms

3855

53970

20x

0sec

0

65536

400ms

7710

57825

60ms

7710

57825

10x

2sec

3855

46260

2sec

3855

46260

200ms

3855

30840

20x

0sec

0

65536

400ms

7710

42405

60ms

7710

57825

Pax7 / p-p65
ICC
Pax7 / p-p65
IHC
eMyHC /
Laminin
IHC
Pax7 /
Laminin
IHC
Pax7 /
MyoD ICC
EdU
ICC
EdU /
Laminin
IHC
TUNEL
ICC

FITC (Green)
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DAPI (Blue)

Flurochromes:
1. Alexa Fluor 488 Goat anti-Rabbit IgG (H+L): Peak Excitation: 490; Peak
Emission: 525
2. Alexa Fluor 546 F(ab’)2-Goat anti-Mouse IgG (H+L): Peak Excitation: 556;
Peak Emission: 573
3. DAPI: Peak Excitation: 358; Peak Emission: 461
Detailed Specifications for ICC/IHC Imaging:
1. Camera Name: Andor Zyla VSC-00439
2. Numerical Aperture: 0.75 Refractive Index: 1
3. Number of Picture Planes: 3
a. Plane #1: DAPI
b. Plane #2: FITC
c. Plane #3: TRITC
4. Modality: Widefield Fluorescence
5. Camera Settings:
a. Camera Type: Andor Zyla
b. Binning: 1x1
c. Exposure: See chart on previous page.
d. Readout Mode: Rolling shutter @ 16-bit
e. Readout Rate: 560 MHz
i. Conversion Gain: Dual Gain ¼
f. Spurious Noise Filter: On
i. Sensor Mode: Overlap
g. Trigger Mode: Internal
h. Temperature: -0.4 C
6. Microscope Settings:
a. Microscope: Ti Microscope Nikon Ti
b. Voltage: -1.0
c. Light Path: R100
d. Zoom: 1.00x
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